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Abstract
Objectives. The purpose of this Thesis is to Create a Critical Review that
describes the methods, results, and conclusions of a literature review of the
benefits and harms of hyperbaric oxygen therapy (HBOT) and the relation
to the free radical production "Oxidative Stress", the usage of the (HBOT)
for brain injury, cerebral stroke, and some neurological disorders.
Selection Criteria. We independently assessed each title and abstract using
Predetermined inclusion criteria based on intervention, population,
outcome measures, and study design criteria. Full papers, reports, and
meeting abstracts that met inclusion criteria were retrieved and reviewed
independently.
Main Results. Determine whether the benefits of HBOT outweigh the
potential harms. For other types of brain injury, no good- or fair-quality
studies were found. No controlled trial of HBOT was designed to measure
mortality in stroke patients, and the best studies found some what
improvement in neurological outcomes. Evidence about the type,
frequency, and severity of adverse events in actual practice is inadequate.
Reporting of adverse effects was limited, and no study was designed
specifically to assess adverse effects. Evidence from well-conducted
clinical studies is limited. The balance of benefits and harms of HBOT for
brain injury, cerebral palsy, or stroke has not been adequately studied.
Key words: HBOT, HBO, Hyperbaric oxygenation, Free radicals,
oxidative stress, Stroke, cerebral stroke, brain injury, stroke.
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1 Introduction
Adopting it as a therapeutic agent from a deep sea commercial diving and
from navies around the glob. The medical profession has been
administrating the Hyperbaric Oxygenation as a part of treatment for
certain criteria and patients, whom they could go under this therapy. We
believe as any other type of therapy which was brought to us through our
ancestors and Science, that every therapeutic tool by the end of the day we
want to improve our patients outcome, patient who suffered from traumatic
brain injuries, stroke, neurological disorders, so many doctors have given
up on them, and they decided that their patient have to accept their faith.
We believe that we could help patient more than only administrating
medical and pharmaceutical medications, which goes hand in hand with
other type of therapeutic methods, the medical field in this new era consist
of multidisciplinary work. The concept of the HBOT comes from the
oxygen and diving. As I was undergoing my diving and taking my course I
came into mentioning the HBOT as a main treatment for nitrogen necrosis
in divers. We thought about the possibility of the oxygen intake in other
disorders and specifically neurological patients. So we decided after the
encouragement of my supervisor PhDr. Michaela Prokesova and
Colleagues' from the Kladno City (See Acknowledgment) to take this topic
as my thesis, and since the first part was already done by my Colleague
Tufikameni Jason. We decided to answer the questions, which was related
to the HBOT and the relation to the free radicals productions?
This evidence report describes the methods, results, and conclusions of a
literature review on the use of hyperbaric oxygen therapy (HBOT) to treat
manifestations of brain injury, and stroke in humans. And the relation of
production of free radicals during or after the exposure to the HBOT.
Hyperbaric oxygen therapy is the administration of high concentrations of
oxygen within a pressurized chamber. HBOT has become the definitive
therapy for patients with decompression illness, gas embolism, and severe,
acute carbon monoxide poisoning and is a widely accepted treatment for
osteoradionecrosis, soft tissue radionecrosis, wound healing, and several
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other conditions. However, the role of HBOT in the treatment of patients
with brain injuries, stroke and some neurological disorders is controversial.
Hyperbaric Oxygen Therapy which is highly effective 300-year-old
treatment modality called hyperbaric oxygenation, its is a very important
medical tool of great potential and importance. HBOT Which is an
abbreviation for the Hyperbaric Oxygen therapy, is a method of restoring
wellness and utilization of the principles pertaining to gases and their
physiological effects. These effects can reverse pathological states in which
the fact that too little oxygen is reaching the cells ( a condition which called
hypoxia). When HBOT is used, the oxygen molecules are up to ten times
more abundant than they are in air. Hardly any more oxygen to be imparted
to the hemoglobin. But the bulk of the blood, called blood plasma, which
essentially water, dissolves some oxygen.
In this thesis we would like to suppress on the HBOT we will go through
the studies and the experimental procedures which were done with the use
of HBOT, we will review the production of free radicals " Oxidative
Stress" which the new era of Scientific Community, are separated into two
main criteria. Either they are with the treatment or contradicting it. We will
go in a systemic way through a basic history and principle of the HBOT,
then we will review some basic concept of the Free Radicals " Oxidative
Stress", we will follow up with an Antioxidants, then we will go through a
Basic aspect of Stork, types of stroke and it Mechanisms.
We will try to answer some of the Scientific Questions, which are debating
the use of HBOT in modern medicine and specifically in Stroke, and some
other neurological disorders. The questions are based on:
What is the relation between HBOT and free radicals "Oxidative stress"?
Dose the Dosage and exposure time in the chamber enhance the production
of free radicals?
Dose antioxidant and other medicaments maintain the production of free
radicals?
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2 Aims and Goals
2.1 Aim:
To find the evidence in relation between the hyperbaric oxygen therapy and
the production of free radical, via critical review.
2.2 Goals:
Gl: Propose and critically review the hyperbaric medicine, definition, and
its mechanism of action and general indications.
G2: Critical review literatures, attempting to treat different neurological
disorders via HBOT, as well some other studies in relation to the
production of free radicals "oxidative stress".
G3: Critical review of literatures the Correlation ofhyperbaric medicine in
different treatment, a review of the main studies which were done for
neurological disorders.
G4: Critical review of literatures, on the oxidative stress and relations to
aging and stroke.
G5: I will review various literatures about Strokes, types of stroke and risk
factors and pathology and mechanism of stroke.
Further more towards the goals of this thesis is to search and find if there is
proper dosage and duration HBOT in stroke patient or overall different
neurological disorders, if any organization or community sit a specific
protocol which is applied been followed by medical practitioners'.
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3 General Part
In this thesis we decided to carry out a critical review, will be reviewing the
articles systematically and we will analysis the outcome's and the result's
of the studies. We will be reviewing articles of patients and studies, which
were experimental on animals and patients', the studies, which were
controlled, uncontrolled, and randomized. We will review the HBOT and
its effects according to the UHMS Under Sea and Medical Society, and the
international standards. The analyses of individual studies reviewed for
quality and consistent evidence for each key question is based on the
sufficient Evidence, Validity of the information also regarded Author's
opinion and advices due to there experience's in the case of the hyperbaric
oxygenation we also included arguments of these anthers about hyperbaric
oxygenation and oxidative stress. The quality of all trials in the review was
assessed using a list of items indicating components of internal validity.
We modified the standard checklists to address issues of particular
importance in studies of HBOT. For randomized controlled trials (RCTs)
and nonrandomized controlled trials (NRCTs).
3.1 History
Hyperbaric therapy was first documented in 1662, when Henshaw built the
first hyperbaric chamber, or "domicilium", since this time, report of
beneficial effects from increased pressure have increased and in 1877,
chambers were used widely for many conditions, though there was little
scientific rationale or evidence, in 1879, the surgical application of
hyperbaric therapy in prolonging safe anesthesia was realized and explored.
In 1927, Cunningham reported improvement in circulatory disorders at sea
level and deterioration at altitude, and a patient who was grateful to
Cunningham for his recovery after HBOT, built the huge 'steel ball
hospital' chamber but this was closed when Cunningham failed to produce
evidence for it use (Jain, 2004)
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Early chambers used compressed air rather than oxygen, due to early
reports of oxygen toxicity. Drager was the first to explore the use of
pressurized oxygen in decompression sickness, and Behnke and Shaw put
his protocols into practice in the late 1930s. Researcher conducted by the
US military after the Second World War brought greater knowledge about
survivable pressures. As a result, the use of HBO increased, and thought
the late 1950s and early 1960s, HBO was used to potentiate radiotherapy
effects, prolong circulatory arrest during surgery, and to treat anaerobic
infections and carbon monoxide poisoning, unfortunately HBO has also
been used without a solid evidence base in condition such as dementia,
emphysema and arthritis. Concerns about the lack of scientific progress and
regulation led the UHMS "Undersea and Hyperbaric Medicine and
Society" to form a Committee on Hyperbaric Oxygen Therapy in the late
1970w, which is now the international authority on HBO (Gill & Bell,
2004; Jain, 2004).
Oxygen free radical's are products of normal cellular oxidation- reduction
processes. Under conditions of Hyperoxia their production increases
markedly. The nature of the oxygen molecule makes it susceptible to
univalent reductions in the cells to form a superoxide anion (O2-) a highly
reactive, cytotoxic free radical, in turn, other reaction product of oxygen
metabolism, including hydrogen peroxide (H2O2), hydroxyl (OH'), and
singlet oxygen (1O2), can be formed. These short-lived forms are capable
of oxidizing the sulfhydryl (SH) groups of enzymes, interact with DNA and
promots lipoperoxidation of cellular membranes. Animals studies showing
the effect of HBOT in raiding the cerebral peroxide content and correlating
with CNS tocxicity (Jain, 2004)
There is a hypothesis of oxygen toxicity which was reproduced from
[Chance and Boverix 1978, (Jain, 2004)].
Hyperbaric Oxygen Therapy which is highly effective 300-year-old
treatment modality called hyperbaric oxygenation, its is a very important
medical tool of great potential and importance. HBOT Which is an
abbreviation for the Hyperbaric Oxygen therapy, is a method of restoring
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wellness and utilization of the principles pertaining to gases and their
physiological effects. These effects can reverse pathological states in which
the fact that too little oxygen is reaching the cells ( a condition which called
hypoxia).
Oxygen Toxi city
Metabolism of oxycjen
via free radicals
Unknown mechanism
Lipoperoxides
i >i:;mption of membranes
Oxidation of SH groups
Enzymes inhibited
Oxidation of glutathtone
Oxidation of pyrioine
riucleotides
Impaired energy
production
Cell injury
i .--.Hi • ! « • < ! mombranes, impaired mitochondria, impaired neurotransmission,
inhibition of nuclear function and/or protein synthesis)
i
Cell death
Figure 1: The hypothesis schema of the oxygen toxicity (Jain, 2004)
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Table 1: Animal experimental studies that were done to see effect of HBO on Brain
Lipoperoxide Levels: (Jain, 2004)
Auther Pressure Effects
Zirkle et al
(1965)
4 ATA Clinical levels of CNS toxicity correlated
with elevated lipoperoxide content;
convulsions were considered to be due to
raised AChE ( acetylcholineserase) activity
Galvin(1962) 2 ATA Cerebral peroxide level not elevated; no
difference in the peroxide level between
convulsing and nonconvulsing animals
Jerrett et al
(1973)
5 ATA H2O2 level were elevated except in those
animals given supplemental alpha-
tocopherol
Yusaetal(1987) 3 ATA Rise of H2O2 level in brain by 300% when
symptoms of CNS toxicity became apparent
Torbati et al
(1992)
3 ATA Direct demonstration of reactive oxygen
species before onset of CNS convulsion
3.2 Critical review
We will began by explaining some basic terms of HBOT and how it works.
It is easier to understand the concept of HBOT if we understand some of
the basic terms. One of these terms is atmospheric pressure. The air around
us exerts pressure because its weight, that is being pulled towards the earth
center by gravity. Atmospheric pressure decreases as one climbs above sea
level because the column of air over one's head weighs less the higher one
goes. As one dives below the surface of the ocean, pressure increases
because of the column of water above one's head weighs more than air.
This water pressure is called hydrostatic pressure.
As we will go through this paper work we will try to explain some basic
terms and knowledge of the free radical's and how its sets on attacking our
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bodies. The free radicals are normally produced in our body via the
Mitochondria , which is the power of the cell in production and functioning
organ. A free radical defined as; any species capable of independent
existence that contains one or more unpaired electrons, (e.g. of free radicals
are Superoxide (O2) and hydroxyl (OH) both oxygen-centered radicals,
most biological molecules are non-radical containing only paired electrons,
when non-radicals and radicals react together free radical chain reaction
often result (Slater, 1984; Thomas, 1998; Wu & Cederbaum, 2003).
We will then go through the deep analyzing of the free radical's risk
factors, which involve aging and DNA damage. We will further expose the
antioxidants and their effects on vivo. And last but not least we will explain
the stroke. Stroke was defined according to the World Health Organization
(WHO), criteria as rapidly developed clinical signs of focal disturbance of
cerebral function, lasting for 24 h, or leading to death, with no other
apparent cause than cerebrovascular disease. (Abo K, 1980). We would like
to answer the questions which were mentioned earlier and if the HBOT is
harmful.
3.2.1 Hyperbaric medicine (Hyperbaric oxygenation
therapy)
I N T R O D U C T I O N OF HBOT
As well known, the origins and development of hyperbaric medicine are
closely tied to the history of diving medicine. While the attraction of the
deep sea's are easily understood, it was various unpleasant physical
consequences of venturing beneath the surface of the world's oceans that
led directly to the many applications of compressed gas therapy in modern
medicine.
Hyperbaric Oxygen Therapy is defined by the Committee on Hyperbaric
Medicine as " A mode of medical treatment in which the patient is entirely
enclosed in a pressure chamber and breathes 100% Oxygen at a pressure
20
greater than 1 atmosphere absolute (ATA) ". The unit of Pressure is ATA, 1
ATA is equivalent to 760 mm of Mercury or pressure at sea level.
The application of HBO depends on the physical properties of gases under
pressure, specifically, oxygen at pressure greater than latm. Oxygen is
essential in a variety of enzymatic, biochemical, and physiologic
interactions that promote normal cellular respiration and tissue function.
Mono-oxygenase, intradioxygenase, and interdioxygenase are specific
enzymes that recruit oxygen as a cofactor to perform required biologic
processes. Collagen deposition and synthesis depend on an oxygen
dependent prolyl-hydroxylase hydroxylation of proline. Angiogenesis and
epithlization are also oxygen dependent (Jain, 2004).
Hyperbaric oxygen (HBO) therapy can be defined as intermittent inhalation
of 100% oxygen, at a pressure greater than 1 atmospheric absolute (ATA),
it can increase oxygen tension in arterial blood and tissue, improves the
cellular oxygen supply by raising the tissue-cellular diffusion gradient,
promote angiogenesis, and decrease the diameter of bubbles in gas
embolism (Gill & Bell, 2004; W. Liu, et al., 2008)
PHYSICAL, PHYSIOLOGICAL, AND B I O C H E M I C A L ASPECTS OF
HBO
Oxygen is the most prevalent and most important element on earth. A Brief
description of how oxygen is transported and the basic physical law
governing its behavior will be useful to understand the principle of the
HBOT.
Partial pressure P
Partial pressure of Oxygen pO2
Partial pressure of Oxygen in alveoli pAO2
Partial pressure of Oxygen in arterial blood paO2
Partial pressure of Oxygen in venous blood pvO2
mmHg millimeter of mercury
in Hg inches of mercury
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psi pounds per square inch
bar bar
kg/cm2 kilogram per square meter
fsw, msw feet or meters of seawater
atm atmosphere
ATA atmospheric absolute
The atmospheric is a gas mixture containing by volume 20.94% oxygen,
78.08% nitrogen, and 0.04% CO2 and traces of other gases. For practical
purposes we will consider the air to be mixture of 21% oxygen and 79%
nitrogen. The total pressure of this mixture at sea level is 760 millimeters of
mercury (mmHg).
Theoretical consideration of hyperbaric medicine
The only absolute atmospheric pressures are those measured by a mercury
barometer. In contrast, gauge pressures are measure of difference between
the pressure in a chamber and the surrounding atmospheric pressure. To
convert pressures as measured by a gauge to ATA requires addition of the
barometric pressures.
Dalton's law states that in a gas mixture, each gas exerts its pressure
according to its proportion of the total volume.
Partial pressure of gas= (absolute pressure) x (proportion of total volume of
gas).
Thus, the partial pressure of oxygen (pO2) in air is
(760) X (21/100)= 160 mmHg.
Boyel's law states that at a constant temperature, the pressure and volume
of a gas are inversely proportional. This is the basis for many aspects of
hyperbaric therapy, including a slight increase in chamber temperature
during treatment; and the phenomenon known as "squeeze", occurring
when blocked Eustachian tubes prevent equalization of gas pressure,
resulting in painful compression of gas in the middle ear. In patients who
cannot independently achieve pressure equalization, the placement of
tympanostomy tubes should be considered to provide a channel between
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inner and outer ear spaces. Similarly, trapped gas can enlarge dangerously
during compression, such as in the rare examples of a pneumothorax
occurring at pressure.
Henry's law states that the amount of gas dissolved in a liquid or tissue is
proportional to the partial pressure of that gas in contact with the liquid or
tissue. This is the basis for increased tissue oxygen tension with HBO
treatment. However, it also has implications for decompression needs in the
air-breathing attendants in multiplace chambers, as their tissue
concentration of inert gases ( particularly nitrogen) will also be increased.
This nitrogen will dissolve in the blood and may come out of solution and
form arterial gas emboli during depressurization.
Most oxygen carried in the blood is bound to hemoglobin, which is 97%
saturated at atmospheric pressure. Some oxygen is however carried in
solution, and this portion is increased at pressure due to Henry's law,
maximizing tissue oxygenation. When breathing normobaric air, arterial
oxygen tension is approximately 100 mmHg, and tissue oxygen tension
approximately 55 mmHg. However 100 % oxygen at 3 ATA can increase
arterial oxygen tension to 2000 mmHg, and tissue oxygen tensions to
around 500 mmHg, allowing delivery of 60ml oxygen per liter of blood
(compared to 3ml/l at atmospheric pressure), which is sufficient to support
resting tissues without a contribution from hemoglobin, as the oxygen is in
solution, it can reach physically obstructed areas where red blood cells
cannot pass, and can also enable tissue oxygenation even with impaired
hemoglobin oxygen carriage, such as in carbon monoxide poisoning and
severe anemia. (Gill & Bell, 2004; Jain, 2004)
The major site of utilization of molecular oxygen within the average cell is
the mitochondria, which account for about 80%, while 20% is used by
other sub cellular organs, such as microsoms, nucleus, the plasma
membrane, etc. Oxygen combines with electrons derived from various
substrates to release free energy. This energy is used to pump H+ ions from
the inside to the outside of the mitochondria against an electrochemical
gradients. As H+ ions diffuse back, free energy is made available to
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phosphorylates adenosine diphosphate (ADP), and adenosine triphosphate
(ATP) is generated. Only a minute amount of oxygen required for the
normal intracellular chemical reactions to take place. The respiratory
enzyme system is so geared that when tissue pO2 is more than 1-3 mmHg,
oxygen availability is no longer a limiting factor in the rate of chemical
reaction.
Density
As barometric pressure rises there is an increase density of gas breathed,
the effect of increased density on resting ventilation is negligible within the
range of the 1.5-2.5 ATA usually used in HBO. However with physical
exertion in patients with decreased respiratory reserves or respiratory
obstruction, increased density may case gas flow problems.
Temperature
The temperature of the gas rise during compression and falls during
decompression, according to Charle's law, if the volume remains constant,
there is a direct relationship between absolute pressure and temperature.
2- A l v e o l a r . i i r
nous blood
5-Heart 6-Svstemk j r t e rv
( I K l . l . : p rnoxoi iu ' , I ' l u l n p
' t n . u l u i n , mitochondria
Figure 2: Physiology of oxygenation (Jain, 2004)
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Ventilation phase
Oxygen is continuously absorbed into the blood, which moves through the
lungs, at a ventilatory rate of 5 liters/min oxygen consumption of 250
ml/min. the alveolar oxygen tension is maintained at 104 mmHg. During
moderate exercise the rate of alveolar ventilation increases fourfold to
maintain this tension and about 1,000 ml of oxygen are absorbed per
minutes. Carbon monoxide is being constantly formed in the body and
discharged into the alveoli secretion is 40 mmHg. It is well know that
partial pressure of alveolar CO2 (pCO2) increases directly in proportion to
the rate of CO2 excretion and decreases in inverse proportion to alveolar
ventilation (Jain, 2004)
HBO AND R E T E N T I O N OF CQ2
When HBO results in venous blood being 100% saturated with oxygen,
there is a rise in blood pCO2 and a shift of pH to the acid side. This is due
to loss of hemoglobin available to transport CO2. This affects only the 20%
of the venous content of CO2, which is transported by hemoglobin. Excess
CO2 is transported by the H2CO3/HCO3 mechanism, as well by entering
into physical solution in plasma. The elevation of cerebral venous pCO2 is
of the order of 5-6 mmHg when venous hemoglobin is 100% saturated with
oxygen. CO2 dose not continue to rise in venous blood and the tissues as
long as the blood flow remains constant, and the presents no major
problems. (Jain, 2004)
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Tissue oxygen tension under HBO
Various factors relating to tissue oxygen tension under HBO:
> arterial pO2 is the maximum pO2 to which any tissue will be
exposed, and plays a major part in determining the pO2 diffusion
gradient driving oxygen into the tissues. Arterial pO2 depends on
the inspired pO2.
> Arterial pO2 content is the total amount of oxygen available, it
depends on the inspired oxygen and the blood hemoglobin level.
> Tissue blood flow regulates the delivery of oxygen to the tissue
> Tissue oxygen levels vary according to utilization of the
available oxygen,
In typical tissue, arteriovenous oxygen difference rises to 350 mmHg when
100 % oxygen is breathed at 3 ATA if half reduces the blood flow to the
tissues, the corresponding values of capillary pO2 will be 288 mmHg and
50 mmHg. Another factor is the vasoconstriction effect of HBO, which
reduces the blood flow. Effective cellular oxygenation can be accomplished
at very low rates of blood flow when arterial pO2 is very High(Jain, 2004)
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Figure 3: Effect of Hyperoxia (Jain, 2004)
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EFFECT OF HBO T R E A T M E N T ON PLASMA BLOOD V O L U M E
A N D H E M O G L O B I N
Since oxygen is transported to the tissue in the blood stream, interputation
of blood flow means that the amount of available oxygen to the cells falls
to zero. Under these conditions, the rate of tissues utilization of oxygen
blood is limited. The effect between hemoglobin reactions on transport of
CO2 is known as Haldane effect, result from the fact that combination of
oxygen with hemoglobin causes it to become stronger acid. This displaces
CO2 from the blood in two ways:
> When there is more acid, hemoglobin has less of a tendency to
combine with CO2 to form carbhemoglobin , much of the CO2
present in this form in the blood is thus displaced.
> The increase of acidiy of hemoglobin causes it to release an excess
of H+ ions and these, in turn, bind with bicarbonate ions to form
carbonic acid, which then dissociates into water and CO2, which is
released from the blood into the alveoli.
Under a normal conditions with a good perfusion at rest, tissues require 5-6
mL per dL of oxygen this can be dissolved or hemoglobin-bonded oxygen.
Increasing the pressure to 3 atm increases the blood oxygen (dissolved
oxygen not carried by hemoglobin) to 6 mL per dL (Jain, 2004; Sheridan &
Shank, 1999).
A classical study on the subject of life without blood was made by
(Boerema I, 1959), the author lowered the level of hemoglobin in young
pigs to 0,4% by exchanging the blood for plasma by venesection. The
animals breathing oxygen at a pressure of 3 ATA in the hyperbaric
chamber lived for 45 min with a level of hemoglobin that would be
incompatible with life at atmospheric pressure. These animals were kept
alive virtually without any hemoglobin. ECG showed no changes, and the
circulation and the blood pressure remained spontaneously normal.
Recovery was uneventful after reinfusion of blood prior to decompression
to the surface. (Bockeria LA, 1979) reported use of hemodilutation up to
55%. HBO was able to provide adequate oxygenation during open-heart
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surgery. (Koziner VB, 1981) replaced 94%-98% of the blood volume with
dextran in cats and kept them alive for 8-9 h, breathing 100% oxygen.
Blood-Brain and Cerebrospinal Fluid-Brain Barriers
Blood-Brain Barrier (BBB), and effect of HBO on the (BBB)
The blood-brain barrier depends on the unique characteristics of the brain
capillaries.
Continuous tight junctions join the endothelial cells of brain capillaries. In
addition, most brain capillaries are completely surrounded by a basement
membrane and by the processes of supporting cells of the brain, called
astrocytes.
The BBB permits passage of essential substances while excluding
unwanted materials. Reverse transport systems remove materials from the
brain. Large molecules such as proteins and peptides are largely excluded
from crossing the blood-brain barrier. Acute cerebral lesions, such as
trauma and infection, increase the permeability of the blood-brain barrier
and alter brain concentrations of proteins, water, and electrolytes.
Some earlier animal experimental studies indicated that HBO increase the
permeability of the cerebral vessels' walls in normal animals. BBB is
disturbed in certain disorders such as cerebrovascular ischemia, and HBO
may decrease the permeability of BBB(Mink RB, 1995a )
Cerebrospinal Fluid-Brain Barrier (CSF) & HBO effect on (CSF)
The ependymal cells covering the choroid plexus are linked together by
tight junctions, forming a blood-CSF barrier to diffusion of many
molecules from the blood plasma of choroid plexus capillaries to the CSF.
Water is transported through the choroid epithelial cells by osmosis.
Oxygen and carbon dioxide move into the CSF by diffusion, resulting in
partial pressures roughly equal to those of plasma. The high sodium and
low potassium contents of the CSF are actively regulated and kept
relatively constant. (Hollin SA, 1968) studied the effect of HBO on the
oxygen tension of Cerebrospinal fluid (CSF) and they found that CFS levels
usually reflect the arterial pO2 tensions.
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EFFECT OF HBO ON C E R E B R A L B L O O D FLOW
Various studies were done regarding the cerebral blood flow, it generally
recognized that oxygen has a vasoconstrictive action and reduces CBF,
thought the mechanism is unknown. Extracellular superoxide dismutase
plays a critical role in physiological response to oxygen in the brain by
regulating nitric oxide (NO) availability (K.K.Jain, 2004). Recent studies
have shown the implication of NO as a mediator of CNS oxygen toxicity.
NO is formed from arginine by the action of one of three different nitric
oxide synthesis (NOS), isozymes which are two calcium-dependent forms,
(nNOS) and endothelial (eNOS), and one calcium-independent form
(iNOS). The role of NO in epilepotgenesis was supported by two lines of
evidence; (1) NO concentration in brain increase during exposure to HBO;
(2) NOS inhibitors, which block NO production, can protect rats and mice
against hyperoxic seizures (N. Bitterman, Bitterman, H.,, 1998; Chavsko,
1998; Thorn, 2002)
According to the calcium-dependant NOS played a dominant role in the
HBO-induced seizures (Mikulas Chavko, Xing, & Keyser, 2001)
There is a large conflict in the reports in this matter and arises from the
variable effect of HBO on the normal versus the injured brain. If CBF is
impaired by cerebral edema or raised ICP it can be improved by HBO.
(Jain, 2004; Leninger-Follert E, 1977) made an observation on the
microcirculation and cortical oxygen pressure, during and after prolonged
cerebral ischemia, that is relevant to the effect of HBO. According to these
authors, complete cerebral ischemia of 1 h in cats followed by reactive
hyperemia, and recirculation as well as reoxygenation of the brain can
occur. Despite there would be a critical phase of a few hours after the
recommencement of circulation as soon as reactive hyperemia ceases. If the
brain swelling occurs can be prevented , however, the distribution of
oxygen pressure in the cortex can be restored to normal, therefore HBO has
a beneficial effect on cerebral edema.
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Brain
in ju ry
Figure 4: Hypoxia as a central factor for edema (Jain, 2004)
TYPES OF H Y P E R B A R I C C H A M B E R S AND G E N E R A L
I N D I C A T I O N S OF THE HBOT
In hypoxia conditions, whether due to ischaemia or other factors, HBO
reduces infection and cell death and maintains tissue viability while healing
occurs. HBO is widely accepted as the only treatment for decompression
sickness (DCS) and arterial gas embolism and the UHMS lists thirteen
conditions for which'... research data and extensive positive clinical
experience have become convincing (Gill & Bell, 2004)
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There are several type of hyperbaric chambers, and the main concern is
monoplace chamber which is a single chamber were the patient is laying on
his back and the chamber it has several advantages main focuses is giving
the patient a privacy and isolation of the patient in case of infectious
diseases and the face mask is not required. Multiple chamber which could
hold up to number of patients, the capacity is varies from a few to many as
20 patients the advantages of this chamber is simultaneous treatment of a
large number of patients is possible, there is a reduced fire hazard, physical
therapy can be performed during the treatment. Mobile chamber the first
mobile chamber was constructed in the form of a bus in Nagoya, Japan but
it is no longer in use. The advantages of this chamber that is portable which
is easy to have and carry according to the situation in case of medical
emergencies, it is comfortable and safe, it is an ideal for clinical use as well
researchers, its suitable for military use (Gill & Bell, 2004; Jain, 2004).
Table 2: Types of chambers (Jain, 2004).
Type Pressure
I Up to 1.5 ATA Mobile and
multiple
II Up to 2.5 ATA
Up to 3.0 ATA
III Up to 6.0 ATA
Monoplace and
portable
Multiplace
chamber
• t iypical indications
Ischemia disorders: cerebral,
cardiac, peripheral-vascular:
adjuvant to physical therapy and
sport medicine; adjuvant to survival
of skin flaps acoustic trauma
Gas gangrene, Burns, crush injuries
of extremities Emergency treatment
of decompression sickness
Air embolism, Decompression
sickness.
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I N D I C A T I O N S VS. C O N T R A I N D I C A T I O N S A C C O R D I N G TO
I N T E R N A T I O N A L S T A N D A R D A N D U H M S
Contraindications of hyperbaric medicine:
(Barnes, Bates, Cartlidge, French, & Shaw, 1985; Buras, Stahl, Svoboda, &
Reenstra, 2000; Cabigas, et al, 2006; Chang, Niu, Hoffer, Wang, &
Borlongan, 2000; Eric P. Kindwall, (September 3, 2004); Gill & Bell,
2004; Harch, Kriedt, Van Meter, & Sutherland, 2007; Jain, 2004; Kapp,
Phillips, Markov, & Smith, 1982; Kudchodkar, Wilson, Lacko, & Dory,
2000; MCDOWALL, 1966; Mink & Dutka, 1995; Murata, Suzuki,
Hasegawa, Nohara, & Kurachi, 2005; Nighoghossian & Trouillas, 1997; S.
B. Rockswold, Rockswold, & Defillo, 2007; Rossignol & Rossignol, 2006;
Rubinstein, et al., 2009; Sheridan & Shank, 1999)
Absolute
Untreated tension pneumothroax
Relative
• Upper respiratory infection
• Emphysema with C02 retention
• Asymptomatic pulmonary lesions seen
on chest X-ray
• uncontrolled fever
• pregnancy
• claustophobia
• seziures disorders
Figure 5 Absolut and retalive contraindications of HBOT
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Uses of HBO Apporved by the
Undersea and Hyperbaric
Medical Society (UHMS):
• Air or gas Embolism
• Carbon monoxide, poisoning & carbon
monoxide poisoning complicated by
cyanide poisoning
• Clostridial myonecrosis (gas gangrene)
• crush injuries, the compartment
syndrome and other acute traumatic
ischemias
• Decompression sickness
• Enhancment of healing in selected
problems wounds
• Exeptional anemia resulting from blood
loss
• Necrotizing soft tissue infections
(subcutaneous tissue, muscle, or fascia)
• Refractory osteomyelitis
• Radiation tissue damage
(osteoradionecrosis)
• Compromised skin grafts and flaps
• Thermal burns
Figure 6: HBOT Indications by UHMS (Jain, 2004)
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International indications of HBOT
•Decompression sickness
•Air embolism
• Poisoning: carbon monoxide, hydrogen, sulfide, carbon tetrachloride
• t reatment of certain infections: gas gangrene, acute necrotizing fascitis,
refractory mycoses, leprosy, osteomyelitis
• Plastic and reconstrective surgery: for nonhealing wounds surgery, as an
aide to the survival of skin flaps with marginal circulation, as an aid to
reimplantation surgery, as an adjucant to the treatment of burns
•Trumatology: crush injuries, compartment syndromes, soft tissue sports
injuries
•Orthopedics: nonunion of fractures, bone grafts, osteoradionecrosis
•periperhal vascular diseases: ischemic gangrene, ischemic leg pain
•peripheral vascular diseases: shock, myocardial ischemia, aid to cardiac
surgery
• Neurological: stroke, multiple sclerosis, migraine, cerebral edema, multi-
infarct dementia, spinal cord injury and vascular diseases of spinal cord,
brain abscess, peripheral neuropathy, radiation myelitis, vegetative coma
• llematology: sickle cell crises, severe blood loss anemia
•Opthamology: occlusion of central artery of retina
•Gastor-interstinal: gastric ulcer, necrotizing enterocolitis, paralytic ileus,
pneumotoides cystoides intest inal is , hepatitis
•for enchancement of radiosensitivity of malignant tumors
•otorhinolaryngology: sudden deafness, acute acoustic trauma,
labyrinthitis, Meniere's disease, malignant otitis externa ( chronic
infection)
•Lung diseases: lung abscess, pulmonary embolism ( adjunct to surgery)
•Obstetrics: complicated pregnancy, diabetes, eclampsia, heart disease,
placental hypoxia, fetal hypoxia, congenital heart disease of the neonate
•Asphyxiation: drowning, near haning, smoke inhalat ion
•Aid to rehabilitation: spastic hemiplegia of stroke, paraplegia, chronic
myocardial insufficiency, peripheral vascular disease.
Figure 7: International indications of HBOT (Jain, 2004)
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O X Y G E N T O X I C I T Y
The pathology of oxygen toxicity has been documented comprehensively in
a classical work on this topic by [Balentine 1982 (Jain, 2004)], it is well
known that the development of pulmonary and CNS toxicity depends upon
partial pressure and the duration of the exposure. Fortunately; the early
effects of poisoning are completely reversible, but prolonged exposure first
lengthens the recovery period and then eventually produces irreversible
changes, many organs have been affected in experimental oxygen toxicity
studies of long exposure to high pressures, a situation that is not seen in
clinical practice (Richard A. Neubauer, 2001)
Pulmonary oxygen toxicity is usually manifestation of prolonged exposure
(more than 24 hour) to normobaric 100% oxygen, as well as during
exposure to HBO from 2 to 3 ATA O2 in human and experimental animals.
The major mechanism by which HBO produces lung injury in rabbits is by
stimulating thromboxane synthesis according to (Jacobson et al 1992, (Jain,
2004); Lung injury induced by free radicals has been demonstrated in an
animal model of smoke inhalation, and the free radicals clear up after about
an hour [Yamagauchi et al 1992 (Jain, 2004)] Normobaric 100% of
oxygen given for one hour dose not increase the level of free radicals in this
model, but HBO at 2.5 ATA dose so (Richard A. Neubauer, 2001)
36
Further more this is some summarized clinical trails and studies, which
failed due to oxygen toxicity:
Hormones: In su l in , thyroid
hormones, adreiii
hormones
m
NH4CI, p a r a i j u a t , aspirin,
disulfirame, guanethidine
ansmitti
Epinephi u
metabolism:
Physical exercises, hyperthermia,
diving
Figure 8: Enhance of oxygen toxicity (Jain, 2004)
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H B O I N N E U R O L O G I C A L D I S O R D E R S
Various neurological conditions where HBOT has been reported to be
useful, there are few controlled clinical studies, the UHMS USA dose not
list any of these conditions (with exceptional to cerebral air embolism) as
approved for payment by third-party insurance carriers.
There are several good reviews of the use of HBO in neurological disorders
we will be adding the indications in neurological disorders briefly in this
Table 3: HBOT in Neurological disorders (Barnes, ct al., 1985; Cabigas, et al., 2006; Chang,
et al., 2000; Gill & Bell, 2004; Harch, ct al., 2007; Hajaka^va, Kanai, Kuroda, Yamaela, &
Mogami, 1971; Jain, 2004; Kapp, ct al., 1982; Koch & Vermeulen-Cranch, 1962; Kudchodkar,
et al., 2000; MCDOWALL, 1966; Nighoghossian & Trouillas, 1997; S. B. Rocksnold, ct al.,
2007; Rossignol & Rossignol, 2006; Rubinstein, ct al., 2009; Sheridan & Shank, 1999; Zhang,
Lo, Mychaskiw, & Colohan, 2005)
1. Cerebrovascular disease: Acute cerebrovascular occlusive
disease, Chronic post-stroke stage, treatment of spasticity, aid to
rehabilitation, adjunct to cerebrovascular surgery, selection of
patients for IC/EC by pass operations on the basis of response to
HBO, Post-operative complications of intracranial aneurysm
surgery: (Cerebral edema and raised intracranial pressure)
2. Cerebral air embolism
3. Head injuries: Cerebral edema raised intracranial pressure
4. Spinal cord lesions
Acute traumatic paraplegia within 4 hours of injury, spinal cord
decompression sickness (Spinal cord "hit"), ischemic diseases of the
spinal cord, aid to the rehabilitation of paraplegia and quadriplegia,
residual neurological deficits after surgery of compressive spinal lesion
5. Cranial nerve lesion: Occlusion of the central artery of the
retina, facial palsy, sudden deafness, vestibular disorders
6. Peripheral neuropathies
7. Multiple sclerosis
8. Cerebral insufficiency (Decline of mental function): multi infarct
dementia
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9. Infection of the CNS and its coverings: brain abscess, meningitis
10. Radiation- induced necrosis of the CNS: radiation myelopathy,
and encephalopathy
11. CO poisoning
12. Migraine headaches
13. Cerebral palsy
14. Autism (A new hypothesis & approach still understudies)
(Yildiz, Aktas, & Uzun, 2008); the author didn't suggest the usage
but some other articles recommended it usage.
Scientific researchers world wide have been researching experimenting the
hyperbaric medicine in different medical cases, there were a big debate on
the use of the HBOT and the main concern were the base line to
recommend indicate the HBOT or to contraindicate the usage of this
method specially in the relation to the production of free radicals.
DNA DAMAGE, FREE RADICALS, OXYGEN TOXICITY IN HBOT
[Dennog and colleagues (C. Dennog, A. Hartmann, G. Frey, & G. Speit,
1996)] they experiment on 10 healthy male volunteers (non-smoker, aged
25-34 years) gave informed consent to participate in this study they were
exposed to 100% O2 at 2.5 ATA, they were given a 3x20 min, interspersed
with 5 min periods of air breathing. With this study we demonstrated for
the first time the induction of oxidative DNA damage by HBO. A clear
reproducible genotoxic effect was seen with the comet assay immediately
after HBO exposure (3x20 min at 2.5 ATA), as used in therapeutically.
Another study was done by [Speit and colleagues (Speit, Dennog,
Eichhorn, Rothfuss, & Kaina, 2000)]; they tested fourteen healthy
volunteers (non-smoker, aged 25-34 years) gave informed consent to
participate in this study, the research was approved by university human
subjects committee. They were exposed to 100% O2 at a pressure 2.5 ATA
39
in HBO for a total of three 20 min periods, interspersed with 5 min periods
of air breathing (standard protocols), or for one or two 20 min periods,
venous blood were taken before HBO, immediately on exit from the
chamber 1 day later. The study shown that treatment of individuals with a
single standard HBO induces adaptation of lymphocytes against the
genotoxic effects of an oxidative agents such as H2O2, they looked for
molecular adaptive response adaptation can be caused by increase in the
level of DNA repair functions or enhancement of general defense against
oxidative reactive species.
[Demurov and colleagues (Demurov, Mil'chakov, Bogdanova, Koloskov
lu, & Tepliakov, 1986)] studied the Daily exposure of rabbits to HBO at
2.5 ATA (in 1-h sessions) for 28 days has been shown to reduce the activity
of antioxidant enzymes and tissue resistance to lipid per oxidation, one of
the consequences was impairment of the cardiac contractile function, and
necrotic foci were observed in the myocardium. A high-pressure oxygen
leads to increased pyruvate/lactate, and pyruvate malate redox couples, as
well as to a decrease in the incorporation of phospholipid long chain-fatty
acid and pyruvate into the tissue lipid. During recovery from the effect of
high-pressure oxygen these changes are reversed. These data indicate that
oxygen poisoning of tissue is not the result of an inhibition of carbohydrate
metabolism, but instead may result from the formation of toxic lipoprotein.
Pulmonary oxygen toxicity is a usual manifestation of prolonged exposure
to normobaric 100% oxygen, as well as during exposure to HBO from 2 to
3 ATA O2 in human and experimental animals (Jain, 2004)
The side effects of pressured oxygen therapy have been noted, especially
for high pressure (>3 ATA) and long duration. It has been shown that HBO
(4.96 ATA for 1 h) administered to rats can cause CNS toxicity. A previous
study has shown that exposing rats to 4ATAat 100% oxygen for 90 min
was associated with an increased level of lipid peroxidation product, and
altered enzymatic anti-oxidation (glutathione peroxidase) in the brain. High
levels of HBO reduced cerebral blood flow, possibly by reducing nitric
oxide syntheses [Chavko et al.(Jain, 2004)] stated that 100% O2 at 5 ATA
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induced seizures. Long duration of HBO at high-pressure levels results in
adverse effects due to the onset of oxygen toxicity as manifested by the
induction of lipid peroxidation and seizures. (Zhang, et al., 2005)
M E C H A N I S M S O F H Y P E R B A R I C O X Y G E N A N D
N E U R O P R O T E C T I O N I N STROKE
Scientific basis
The most important factor determining the effectiveness of HBO in
ischemic stroke is the therapeutic window for treatment. The primary
supposition of HBO therapy in stroke treatment is not to treat the ischemic
core but the surrounded areas that are viable yet non-functioning, where
residual viable neuronal cells might be salvaged. Therefore, the therapeutic
window for intervention with HBO should be similar to that for
thrombolytic therapy, with a window of 3-6 h when the ischemic neuronal
tissues can still be saved (Zhang, et al., 2005).
Historically, the mechanism through which HBO worked was found to be
vasoconstriction of the cerebral blood vessels, which led to decreased CBF
and ICP. The vasoconstriction was not found to be deleterious because O2
availability to the injured cells was greatly increased (S. B. Rocks wold, et
al., 2007).
HBO has an important role in improving the microcirculatory disturbances,
the resistance to blood flow is greater in vessels in which the diameters is
less than 1.5 mm, e.g. the capillaries. The viscous effect is less, because red
blood cells (RBC) are aligned in a column as they pass through lumen
(Farhraeus Lindqvist effect), instead of moving randomly. In
microcirculatory disturbances, such as occur with clumping of RBC and
slowing of circulation, the viscosity of the blood increases tremendously.
RBC can get stuck where the endothelial cells protrude into the lumen of
the capillary. The blood flow can become totally blocked for a fraction of a
second or a longer period. Some plasma may, however. Seep across the
obstruction.
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HBO has a beneficial effect in cerebral ischemia through the following
mechanism (Jain, 2004):
1. Oxygen dissolved in plasma under pressure raises pAO2 and can
nourish the tissues even in the absence of RBC.
2. Oxygen can diffuse extravascularly. Diffusion is facilitated by
the gradient between high oxygen tension in the patent capillaries
and the low tension in the occluded ones, the effectiveness of this
mechanism depends upon the abundance of capillaries in the
tissues', because the brain is a very vascular tissue, this mechanism
can provide for the oxygenation of the tissue after vascular
occlusive.
3. Decreasing the viscosity of the blood and reducing platelet
aggregation and increasing RBC deformability can facilitate the
supply of oxygen to the tissue.
4. HBO relives brain edema, by its vasoconstricting action, HBO
counteracts the vasodilatation of capillaries in the hypoxic tissue
and reduces the extravasations' of fluid.
5. HBO also reduces the swelling of the neurons by improving their
metabolism.
6. HBO, by improving oxygenation of the penumbra that surrounds
the area of total ischemia, prevents glycolysis and subsequent
intracellular lactic acidosis and maintains cerebral metabolism in an
otherwise compromised area.
R A T I O N A L E USE OF H Y P E R B A R I C O X Y G N A T I O N
Breathing atmospheric air at sea level, 0.3 ml of oxygen are dissolved in
each 100 ml of plasma, the remaining 19.1 ml of oxygen being transported
as oxyhaemoglobin. This latter figure cannot be increased once the
hemoglobin is fully saturated. At 2 ATA of pure oxygen 4.3 ml of oxygen
are carried dissolved in each 100 ml of blood, this representing a fourteen-
fold increase in the increased dissolved oxygen. The relative importance of
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these two conflicting factors (the increased dissolved oxygen and the
reduce tissue flow) is uncertain. Experimental work in animals suggested
that the net effect of HBO might be harmful. However [Ashfield and Gavey
1969] showed that the effect was beneficial in man (Thurston, Greenwood,
Bending, Connor, & Curwen, 1973)
REVIEW OF C L I N I C A L S T U D I E S
Animals experiments
No animal model can mimic the human stroke and there are fallacies of
testing neuroprotective compounds in animal models, some of these results
are difficult to translate into human clinical trails. One advantage,
however; of these models is that standard model can be used to compare
various therapies. Stroke models may be quite appropriate for evaluating
the effects of HBO in acute cerebral infarction.
Animal experimental evidence for the effect of HBO well be summarized
in this following table (Jain, 2004; Richard A. Neubauer, 2001, February 7,
2001). (See table at the appendix 1)
Uncontrolled group
Most of the studies of HBOT in acute stroke are uncontrolled. Only a few
controlled studies have been done in recent years and further studies are
planned. Considerable background information can be extracted from the
uncontrolled studies reported in the literature.
Various studies on the clinical application of HBO in cerebrovascular
diseases, as reported in the following table (Jain, 2004; Richard A.
Neubauer, February 7, 2001), the total report cases were over 1000. The
reported rate of improvement were 40% to 100% and is much higher than
the natural rate of recovery, particularly because many of the reported cases
were in a chronic post stroke stage with stable neurological deficits the
major criticism in these studies that none of them were a randomized
control study. (See the table at the appendix 2)
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Controlled clinical trails
Such trails are considered necessary because of the value of HBO therapy
in acute stroke remains controversial. Controlled trails will be required for
proving the efficacy of HBO in acute stroke because it is difficult to prove
that the recovery is due to treatment and natural recovery. The other issue is
demonstrating the safety of HBO in acute stroke patients, for number of
logistic problems, it has not been easy to carry out clinical trails of HBO in
acute stroke. (See the table at the appendix 3)
[Anderson and colleagues', (D. C. Anderson, et al., 1991; Nighoghossian,
Trouillas, Adeleine, & Salord, 1995)] administrated HBO in a double blind
prospective protocol to 39 patients with acute ischemic cerebral infarction.
They aborted the study when no dramatic improvement was notes in the
HBO treated patients. Rather, there was a favoring the control patient
(treated with only air) who has less severe neurological deficits and smaller
infarcts. This trend was considered to be an artifact of randomization
process. The treatment protocol was broken in 19 of 39 patients and 8
patients refused to continue treatment. The results of this trail neither prove
or disapprove the usefulness of HBO in acute stroke and can be
disregarded. They merely point out the difficulties in carrying out such a
trails.
(Nighoghossian & Trouillas, 1997; Nighoghossian, et al., 1995) reported
the result of a randomized trail only on 34 patients. These were enrolled
over a period of three years. Half of these received HBO whereas the other
halves were treated in hyperbaric air. There was no significant difference at
inclusion between the two groups regarding age, time of stroke onset to
randomization, and Orgogozo scale. The mean score of HBO group on the
Rankin score. There authors concluded that HBO was safe in these patients
and there was an outcome trend favoring HBO therapy. They
recommended a large-scale controlled trails. In recent review these, authors
recommend a large double-blind trail of HBO, possibly combination with
thrombolytic therapy.
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(Rusyniak, et al., 2003) conducted a randomized, prospective, double blind,
sham-controlled pilot study of 33 patients presenting with acute ischemic
stork who did not receive thrombolytic over a 24-month period. Patients
were randomized to treatment for 60 min in a monoplace hyperbaric
pressurized with 100% O2 at 2.5 ATA in the HBO group or 1.14 ATA in
sham group. Primary outcomes measured included percentage of patients
with improvement at 24 h using NIHSS scale (National Institutes of
Neurological Disorders and Stroke) , and 90 days (NIHSS, Barthel Index,
modified Rankin Scale, Glasgow Out come Scale), secondary
measurements included complications of treatment and mortality at 90
days. Results revealed no differences between the groups at 24 h. At 3
months, however, a larger percentage of the sham patients had a good
outcomes defined by their stroke scores compared with HBO group (
NIHSS, 80% versus 31.3; P=0.004; Barthel Index, 81,8% versus 50%
P=0.12; modified Rankin Scale, 81.8% versus 50%; P= 0.02; Glasgow
Outcome Scale, 90% versus 37.5%; P=0.01) with loss statistical
significance in a intenet-to-treat analysis. It was concluded that HBO dose
not appear to be beneficial and in face may be harmful in patients with
acute ischemic stroke, the design of this study, however. Invalidate any
conclusions because of HBO at 1.5 ATA has been established to be a safe
pressure to treat patients with acute stroke. The control group was closer to
the parameter.
Random studies with HBOT treatment (see the table in appendix 4}
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3.2.2 Oxygen radicals and the disease processing "Oxidative
Stress" & "Free Radicals"
Disruption of oxygen and glucose supply results in abnormal cellular
metabolisms and various molecular, cellular, and physiological responses
in cells in affected brain regions. Experimental evidence has suggested that
abnormal free radical metabolism contributes, at least in part, to the
damage that occurs after brain ischemia.(H. Shi & Liu, 2007).
A free radical defined as; any species capable of independent existence that
contains one or more unpaired electrons, (e.g. of free radicals are
Superoxide (O2) and hydroxyl (OH) both oxygen-centered radicals, most
biological molecules are non-radical containing only paired electrons, when
non-radicals and radicals react together free radical chain reaction often
result (Slater, 1984; Thomas, 1998; Wu & Cederbaum, 2003).
Free radical consists of two categories: reactive oxygen species (ROS) and
reactive nitrogen species (RNS). One of the major RNS in cerebral
ischemia is nitric oxide (NO), a water and lipid soluble free radical, by the
action of nitric oxide syntheses (NOS). There are three isoforms of NOS
in brain cells, neuronal NOS (nNOS), inducible NOS (iNOS), and
endothelial NOS (eNOS). Neurons produce NO mostly from nNOS
activation. Glial cells generate NO mainly from iNOS activation (H. Shi &
Liu, 2007).
The molecular basis of CNS oxygen toxicity, and also pulmonary oxygen
poisoning, involves generation of reactive oxygen species, (ROS). This is
has been known as the free radical theory of oxygen poisoning. (Jain, 2004)
The presences of free radicals in biological materials was discovered less
than 50 years ago (Scheibmeir, et al., 2005).
Oxygen free radicals are normally produced by the mitochondria during
electron transport, and, after ischemia, high levels of intracellular Ca2+,
Na+, and ADP stimulate excessive mitochondrial oxygen radical
production.(Aneesh B. Singhal, 2006). Free radicals play a key role in both
normal biological function and in the pathogenesis of many disease
processes. These free radicals are continuously formed in the body and are
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exquisitely balanced. When this balance is broken, oxidative stress occurs.
During oxidative stress, cellular lipids, DNA, and proteins are attacked
causing damage to the cells and resulting in a loss of function, integrity,
and ultimately, cellular death (Whitaker & Pierce, 2003).Today there is a
large evidence indicating that patients are exposed to excessive free
radicals, from drugs and other substances that alert cellular reduction-
oxidation (Redox) balance, and disrupt normal biological function
(Scheibmeir, et al., 2005). Most chemical reactions in the body are
"balanced" through reduction and oxidation mechanisms (redox). Redox
reactions primarily involve the transfer of electrons between two chemical
species(Whitaker & Pierce, 2003). The compound that loses an electron is
said to be oxidized; the one that gains an electron is said to be reduced. A
free radical may be defined as any species that has one or more unpaired
electrons. This broad definition includes the hydrogen atom (one unpaired
electron), most transition metals and the oxygen molecule itself. O2 has
two unpaired electrons, each located in a different, orbit anti-bonding
orbital, these two electrons have the same spin quantum number and so if
O2 attempts to oxidize another atom or molecule by accepting a pair of
electors from it, both new electrons muse be parallel spin so as to fit into
the vacant spaces in the orbital's (Halliwell & Gutteridge, 1984).
Most molecules can become free radicals by either losing or gaining an
electron. During this chemical process, molecules can be either reduced or
oxidized. A single electron in an orbital is said to be "unpaired". Thus, a
radical is defined as any species that contains one or more unpaired
electrons capable of independent existence. When electrons are paired, the
molecule is chemically stable in contrast to a molecule with an unpaired
electron. An orbital that has only one electron will try to fill it by "stealing"
another unpaired electron from the orbital of another molecule. The
donation of an electron is called oxidation and the gain of an electron is
called reduction (Whitaker & Pierce, 2003).
The most common ROS include: the superoxide anion (O2-), the hydroxyl
radical (OH •). singlet oxygen (1O2 ), and hydrogen peroxide (H2O2)
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Superoxide anions are formed when oxygen (O2) acquires an additional
electron, leaving the molecule with only one unpaired electron. Within the
mitochondria O2- • is continuously being formed. The rate of formation
depends on the amount of oxygen flowing through the mitochondria at any
given time. Hydroxyl radicals are short-lived, but the most damaging
radicals within the body. This type of free radical can be formed from O2-
and H2O2 via the Harber-Weiss reaction. The interaction of copper or iron
and H2O2 also produce OH • as first observed by Fenton. These reactions
are significant as the substrates are found within the body and could easily
interact (Sandeep Raha, 2001; Thomas, 1998; Zhou, et al., 2007).
Most chemical reactions in the body are "balanced" through reduction and
oxidation mechanisms (redox), redox reactions primarily involve the
transfer of electrons between two chemical species. It is important to
remember that the human body attempts to maintain a balance between the
reactive oxygen species production and the levels of antioxidants. This
balance is often referred to as the "redox potential" and interference of the
balance may lead to cellular damage. Changing balance towards an
increasing in oxidants is called "oxidative stress", and changing the balance
towards an increase in the redacting power, or antioxidants, is called
reductive stress (Whitaker & Pierce, 2003). Reactive oxygen species (ROS)
are small, highly reactive, oxygen-containing molecules that are naturally
generated in small amounts during the body's metabolic reactions and can
react with and damage complex cellular molecules such as fats, proteins, or
DNA. Alcohol promotes the generation of ROS and/or interferes with the
body's normal defense mechanisms against these compounds through
numerous processes, particularly in the liver. For example, alcohol
breakdown in the liver results in the formation of molecules whose further
metabolism in the cell leads to ROS production. Alcohol also stimulates the
activity of enzymes called cytochrome P450s, which contribute to ROS
production (Wu & Cederbaum, 2003).
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Oxidative stress: the term is used in the literature, but rarely defined, in
essence it referees to the situation of a serious imbalance between
produxtion of ROS/RNS and antioxidant defense. Sies introduced a
somewhat-vagye definition in 1992, as a disturbance in the prooxidant-
antioxidant balance in favor of the former, leading to potential damage. In
principle oxidative stress can result from(Richard A. Neubauer, 2001; Sies,
1997):
1. Diminished antioxidant, e.g. mutations affecting
antioxidant defense enzymes.
2. Increased production of ROS/RNS e.g. by exposure to
elevated O2, the presence of toxins that are themselves
reactive species (e.g. NO) metabolized to generate
ROS/RNS, or excessive activation of "natural" ROS/RNS
producting system (e.g. inappropriate activation of
phagocytic cells in chronic inflammatory disease such as
rheumatoid arthritis and ulcerative colitis),
Oxidative stress can result adaptation: by up regulating of defense system
which may (Thomas, 1998):
> Completely protect against damage
> Protect against damage but not completely
>"Over protect", e.g. the cell is then resistant to higher levels of
oxidative stress imposed subsequently.
Metabolic activation and cell injury
Many substances are metabolically activated to a free radical intermediate
through interactions with the NADPH-cytochrome P-450electrontransport
chain, which is located in the endoplasmic reticulum in many types of cell
and involves the flavoprotein NADPH-P-450 reductase and cytochrome P-
450 together in a phospholipid environment. Although P-450 is mainly
located in liver, small amounts of P-450 can be detected in many other
tissues (Slater, 1984).
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I N F L A M M A T I O N I N R E L A T I O N WITH FREE RADICALS A N D
THE BBB TQXICITY
Considerable attention has been directed to a possible involvement of free
radical intermediates in the inflammatory process; in particular, to the
beneficial effects of superoxide dismutase that acts to decrease the
concentration of 02- generated by local metabolic disturbances and by
stimulated white cells attracted to the site by chemotactic agents. Although
(Jain, 2004)form, O2H', is more reactive and in the presence of transitional
metal ions 02- can generate OH which would contribute to the many toxic
effects associated with superoxide production in biological systems. The
phenomenon overall is complex and multiphasic, but an associated key
process is the so-called 'metabolic burst1 during which reduced oxygen
species are produced. Free radical intermediates have been linked recently
to a number of clinically important disturbances including ischaemic
attacks (Slater, 1984).
The toxicity of the abnormal free radical metabolism in cerebral
ischemia/reperfusion results from their modification of
macromolecules, from their effect on signal transduction pathways,
and from the resulting induction of apoptotic and necrotic pathways.
Their involvement in blood brain barrier (BBB) disruption, apoptosis,
and cellular response to hypoxia are discussed as follows (Richard A.
Neubauer, 2001)
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Figure 9: Mitochondria! oxidative stress (Green, C., nbsp, & Reed, 1998; K. Green, Brand,
& Murphy, 2004)
Legend
Mitochondrial oxidative damage. The mitochondrial respiratory chain (top) passes
electrons from the electron carriers NADH and FADH2 through the respiratory
chain to oxygen. This leads to the pumping of protons across the mitochondrial
inner membrane to establish a protonelectrochemical potential gradient (H),
negative inside: only the membrane potential (m) component of H is shown. The
H is usedto drive ATP synthesis by the FOF1ATP syntheses. The exchange of
ATP and ADP across the inner membrane is catalyzed by the adenine nucleotide
transporter (ANT) and the movement of inorganic phosphate (Pi) is catalyzed by
the phosphate carrier (PC) (top left). There are also proton leak pathways that
dissipate H without formation of ATP (top right). The respiratory chain also
produces superoxide (O2), which can react with and damage iron sulfur proteins
such as aconitase, thereby ejecting ferrous iron. Superoxide also reacts with nitric
oxide (NO) to form peroxynitrite (ONOO ). In the presence of ferrous iron,
hydrogen peroxide forms the very reactive hydroxyl radical ( OH). Both
peroxynitrite and hydroxyl radical can cause extensive oxidative damage (bottom
right). The defenses against oxidative damage (bottom left) include MnSOD, and
the hydrogen peroxide it produces is degraded by glutathione peroxidase (GPX)
and peroxiredoxin III (PRX III). Glutathione (GSH) is regenerated from
glutathione disulfide (GSSG) by the action of glutathione reductase (GR), and the
NADPH for this is in part supplied by a
transhydrogenase (TH). (K. Green, et al., 2004)
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THE G E N E R A T I O N OF O X Y G E N FREE RADICALS
BY M I T O C H O N D R I A
Life on earth envolved in changing milieu with respect to oxygen, micro-
organisms that had arisen in a reducing environment, in adapting to
increasing atmospheric level of oxygen, faced a new problem-that of
reactive oxygen species (ROS), produced as a byproduct of normal
metabolism. (Raha & Robinson, 2000)
The oxygen molecule is capable of accepting an additional electron to
create superoxide, a more reactive form of oxygen.
The most oxidinized radical that is likely to arise in a biological system is
the Hydroxyl radical HO°, being at the top order of it can oxidizien all the
reduced species below it. (Buettner, 1993)
Equation 1: Fe(II) complex: (Buettner, 1993)
FedDcomplex + H/)j -»
FedlDcomplex + OH + HO'
Equation 2: Superoxide (Raha & Robinson, 2000)
O2+ le -» O2-
Superoxide is the primary oxygen free radical produced by mitochondria
and is probably produced by a non-enzymic mechanism. Ubisemiquinone
generated in the course of electron transport reactions in the respiratory
chain donates electrons to oxygen and provides a constant source of
superoxide (Sandeep Raha, 2001)
Equation 3: Superoxide on sulfur (Raha & Robinson, 2000)
UQ10+O2= O2- + UQ10
Superoxide can attack iron sulfur centers in enzymes such as aconitase,
succinate dehydrogenase, and mitochondrial NADH-ubiquinone oxido
reductase, releasing iron and destroying catalytic function. Superoxide is,
therefore, rapidly removed by conversion to hydrogen peroxide in a
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reaction catalysed by superoxide dismutases. (Raha & Robinson, 2000;
SandeepRaha, 2001)
Superoxide its self can be toxic, especially through inactivation of proteins
that contain iron-sulphur centers such as aconitase and succinate.
Dehydrogenase and mitochondrial N-methyl-D- aspartate (NADH)-
ubiquinone oxidoreductase, Ferrus iron released during the inactivation
becomes an important reactant in the fenton reaction(Raha & Robinson,
2000)
Equation 4: H202 + Fe++
H2O2 + Fe++ = OH- + OH' + Fe +++
Metabolism strips electrons from fatty acids, sugars, and amino acids and
accumulates them on the soluble electron carrier NADH and on protein-
bound FADH2, the electrons are then passed down the mitochondrial
respiratory chain to drive ATP synthesis by oxidative physphorelation. As
the electrons move down the potential energy gradiant from
NADH/FADH2 to oxygen, the redox energy is conserved by pumping
proton electrochemical potential gradient (K. Green, et al., 2004)
Complex I and superoxide production
Oxidative phosphorylation in mitochondria is carried out by four electron-
transporting complexes (I-IV) and one H+ translocating ATP synthetic
complex (complex V). Two of these complexes were shown to be
responsible for much of the superoxide generated by mitochondria:
complex I, the NADH- ubiquinone oxidoreductase, and complex III, the
ubiquinone-cytochrome c oxidoreductase. (Raha & Robinson, 2000)
Damage caused by mitochondrially generated ROS
Under normal circumstances, the rate of generation of superoxide from
mitochondria is rather low and dose little damage, simply because it is
efficiently removed by the superoxide dismutase's.Circumstances can arise
for a variety of reasons (e.g. ingested chemicals that act as radical
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amplifiers, medically applied high concentrations of oxygen, or during
periods of reperfusion of tissue with oxygen following ischemia). Where
high rates of superoxide production do occur, superoxide itself is especially
damaging to the (4Fe-4S) type of iron-sulphur centre. Damage of
isoenxyme of aconitase evident after exposure to superoxide results in the
release of ferrous ions and also sets in motion an important regulators
mechanism: the deactivated enzyme becomes a binding protein for the
mRNA for ferritin, prolonging its half-life and ensuring increased ferritin
synthesis to bind free iron. The damage to other systems such as
mitochondrial aconitase complex succinate and I dehydrogenase, Damage
of these enzymes by superoxide undoubtedly impairs the normal
functioning of the citric acid cycle. This combined with resulting
inactivation of electron transport processes. Then result in disordered
metabolism with lack of mitochondrial ATP generation, leading to increase
flux from glucose to lactate (Raha & Robinson, 2000).
Mitochondrial ROS production in vivo
The mitochondrial ROS production occurs at all time is suggested by mice
lacking MnDOS, which dise within a few days of birth, which those
lacking the cytosolic isoform Cu,ZnSOD survive, further evidence of
mitochondrial ROS production under normal conditions is the efflux of
hydrogen peroxide from intact mitochondria produce superoxide, which is
then converted to hydrogen peroxide in vivo. There is also evidence that,
under certain conditions, mitochondrial DNA and protein accumulate
greater oxidative damage in vivo than the rest of the cell. Many other
enzymes associated with mitochondria can also produce superoxide or
hydrogen peroxide, but even through their contribution to ROS formation
in vivo is unclear (K. Green, et al., 2004).
54
Superoxide Production From the Respiratory Chain
The mitochondrial respiratory chain is the major site of ROS production
within the cell, Superoxide is thought to be produced continually as a
byproduct of normal respiration through the one electron reduction of
molecular oxygen, superoxide itself damages iron sulfur-center containing
enzymes such as aconitase, and can also react with nitric oxide to form the
damaging oxidant peroxynitrite which is more reactive than either
precursor.
The mitochondrial respiratory chain is made up of four electron-
transporting complexes (I-IV) and one proton translocating ATP synthetic
complex (complex V) Two of these complexes were shown to be
responsible for much of the superoxide generated by mitochondria:
complex I, the NADH-ubiquinone- oxidoreductase, and complex III, the
ubiquinol cytochrome c oxidoreductase.(Sandeep Raha, 2001)
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Legend:
Diagram to show the relationship between the respiratory chain components of
complex I and III and the site of superoxide production. The oxidation of NADH
generated intramitochondrially is achieved by the 51 kDa (K) "avoprotein
containing subunit of complex I which then transfers electrons to its own iron sulfur
center. Subsequently, electron transfer through the 24 kDa and 75 kDa iron sulfur
proteins to the TYKY 23 kDa and finally the PSST 20 kDa iron sulfur proteins
embedded partly in the inner mitochondrial membrane. Final reduction of
ubiquinone to ubisemiquinone and ubiquinol takes place at one, or possibly two,
sites defined by the presence of the 49 kDa and PSST proteins which have
evidence of quinone binding capacity. In complex III, the Rieske iron sulfur protein
to produce ubisemiquinone, which then is oxidized to quinone by the bL heme of
cytochrome b, oxidizes ubiquinol. The electrons are passed to the bH heme,
which then re-reduces the ubiquinone to semiquinone and ubiquinol at the
antimycin A sensitive site close to the mitochondrial matrix face of the membrane.
Cyclic ~own of electrons and reducing equivalents between cytochrome b and
quinone coupled with proton movement and passage of electrons through to
cytochrome c1 and cytochrome c completes the series of transfers. Superoxide
can be generated in at least two places where ubisemiquinones are produced by
simple chemical reaction with molecular oxygen. The superoxide produced can be
transformed into hydrogen peroxide by either manganese superoxide dismutase
or the copper/ zinc superoxide dismutase, depending on the location. Hydrogen
peroxide has two fates. Either it is reduced to water by glutathione peroxidase, or
is converted into the damaging hydroxyl radical if free cuprous or ferrous ions are
available (Sandeep Raha, 2001).
OXIDATION & DAMAGE IN DNA, PROTEIN & LIPIDS ,IN
R E L A T I O N TO A G I N G PROCESS, C A N C E R , B R A I N I N J U R Y
The degenerative diseases associated with aging include cancer,
cardiovascular disease, immune system decline, brain dysfunction, and
cataracts, the functional degeneration of somatic cells during aging appears,
in contribute with these diseases (Ames, Shigenaga, & Hagen, 1993)
Extensive studies with model systems, and with biological materials in
vitro, have clearly shown that reactive free radicals are able to produce
chemical modifications of, and damage to, proteins, lipids, carbohydrates
and nucleotides. Therefore, if such reactive free radicals are produced in
vivo, or in cells in vitro, in amounts sufficient to overcome the normally
efficient protective mechanisms, we can expect metabolic and cellular
disturbances to occurs (Slater, 1984)
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Figure 11: Free radicals and cellular injury (Slater, 1984)
Legend:
Free radicals and cellular injury Major routes are shown in which a reactive free radical
(R1) can interact with neighboring components in cells to disturb their metabolic function
(s) are indicated by the arrows (Slater, 1984)
Oxidative damage to DNA, proteins, and other macromolecules
accumulates with age and has been postulated to be a major, but not the
only, type of endogenous damage leading to aging, superoxide and
hydroxyl radical, which are mutagens produced by radiation, are also by
products of normal metabolism. Lipid epoxides, lipid hydroperoxides, lipid
alkoxyl and peroxyal radicals, and enals. Transfer of energy from lights, the
respiratory burst from neutrophils, or lipid perodication can produce singlet
oxygen, a high -energy and mutagenic form of oxygen. Four endogenous
sources appear to accounts for most of the oxidants produced by cells, (i) as
a consequence of normal aerobic respiration , mitochondria consume O2,
reducing it by sequential steps to produce H2O, (ii) phagocytic cells
destroy bacteria or virus infected cells with an oxidative burst of nitric
oxide (NO). Chronic infection by viruses, bacteria or parasites results in
chronic inflammation, which major risk factor for cancer, (iii) Peroxisomes,
which are organelles responsible for degrading fatty acids and other
molecules, produce H2O2 as a by-product, which is then degraded by
catalase. (iv) Cytochrome P450 enzymes in animals constitute on of the
primary defense systems against natural toxic chemicals from plants the
major source of dietary toxins (Ames, et al., 1993).
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(Caporaso, 2003), the action of modulators of oxidative DNA damage is
the focuses of intense study and contraversory, Lung cancer is a logical
disease for evaluating oxidative damage and the role of free radicals
because the etiologic agents for long cancer are tobacco carcinogens that
are known to damage the DNA.
Oxygen radicals in relations to Brain
Oxygen radical production may be especially harmful to the injured brain
because levels of endogenous antioxidant enzymes [including superoxide
dismutase (SOD), catalase, glutathione], and antioxidant vitamins (e.g.,
alpha-tocopherol, and ascorbic acid) are normally not high enough to match
excess radical formation, after ischemia reperfusion, enhanced production
of ROS overwhelms endogenous scavenging mechanisms and directly
damages lipids, proteins, nucleic acids, and carbohydrates(Aneesh B.
Singhal, 2006).
Inflammatory mediators such as cytokines and associated ROS are
responsible for the pathologic changes related to TSE (Transmissible
spongiform encephalopathy's) (Drisko, 2002).
Smoking, Alcohol and their effect on production of free radicals
Cigarette smoking is the major risk factor for several forms of lung disease,
including chronic obstructive pulmonary disease (COPD) Cigarette
smoking, whidl exposes the lung to high concentrations of reactive oxidant
species (ROS). Recent studies indicate that ROS interfere with protein
folding^ in thd'endoplasmic reticulum and elicit a compensatory response
termed the "unfolded protein response" (UPR). The importance of the
UPR lies in its ability to alter expression of a variety of genes involved in
antioxidant d£$je$se, inflammation, energy metabolism, protein synthesis,
apoptosis, and cell cycle regulation. The gaseous and particulate phases of
cigarette smoke contain more than 4,500 separate compounds, many of
which are highly toxic reactive ox-ygen/nitrogen species (RONS) and
xenobiotic materials (Kelsen, et al., 2008).
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It is estimated that only a minority (i.e., 15-35%) of chronic, continuous
cigarette smokers develop COPD (14, 15). That the majority of long-term
smokers do not develop COPD suggests that failure of compensatory
mechanisms that protect the lung from ROS or xenobiotic materials
contributes to development of the disease (Kelsen, et al., 2008)
Recent studies indicate that a complex molecular cascade termed the
"unfolded protein response" (UPR) plays an important role in the
regulation of expression of a variety of antioxidant, xenobiotic
metabolizing and pro- and anti-inflammatory genes (Kelsen, et al., 2008).
There is little doubt that excessive consumption of alcohol over a
considerable period of time may lead to an impairment of cognitive
function, specific alcohol-related disorders such as Wernicke-Korsakoff
syndrome (WKS), hepatic encephalopathy, and pellagra cause clinical
dementia syndromes, but when these have been excluded there are still a
number of alcoholics who have cognitive deficits (Harper, 2009)
[Shi and Collaegues (W. Liu, et al., 2008; H. Shi & Liu, 2007; X. Y. Shi,
Tang, Sun, & He, 2006)] Production of acetaldehyde during alcohol
metabolism, which through its interactions with proteins and lipids also can
lead to radical formation and cell damage. Damage to the mitochondria
resulting in decreased ATP production, effects on cell structure (e.g., the
membranes) and function caused by alcohol's interactions with either
membrane components (i.e., phosphate containing lipids [phospholipids])
or enzymes and other protein components of the cells.
Alcohol-induced oxygen deficiency (i.e., hypoxia) in tissues, especially in
certain areas of the liver lobules (i.e., the pericentral region), where extra
oxygen is required to metabolize the alcohol.
For more information on alcohol-induced hypoxia in the liver and its
consequences (Wu & Cederbaum, 2003):
Alcohol's effects on the immune system which lead to altered production
of certain signaling molecules called cytokines, which in turn lead to the
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activation of an array of biochemical processes, production and its
consequences, alcohol-induced increase in the ability of the bacterial
molecule endotoxin to enter the bloodstream and liver, where it can activate
certain immune cells.
Alcohol-induced increases in the activity of the enzyme cytochrome P450
2E1 (CYP2E1), which as described in the section "Systems Producing
ROS" metabolizes alcohol and other molecules and generates ROS in the
process (Wu & Cederbaum, 2003).
Alcohol-induced increases in the levels of free iron in the cell (i.e: iron
that is not bound to various proteins), which can promote ROS generation,
as described in the section "Role of Metals biochemical reactions
generating an alcohol-derived radical (i.e., the 1-hydroxyethyl radical)
Conversion of the enzyme xanthine dehydrogenase into a form called
xanthine oxidase, which can generate ROS(Wu & Cederbaum, 2003)
Many of these processes operate concurrently, and it is likely that several,
indeed many, systems contribute to the ability of alcohol to induce a state
of oxidative stress (Wu & Cederbaum, 2003).
Based on the wealth of evidence that has accumulated over the past decade,
it is clear that free radicals, and the resulting oxidative stress, are involved
in cell death and brain injury after stroke (H. Shi & Liu, 2007)
A N T I O X I D A N T S
Antioxidant supplements and diets have long been advocated for the
treatment of rheumatoid arthritis (RA), osteoarthritis (OA) and other
inflammatory arthritis. However, the value of antioxidants in the prevention
and treatment of a wide range of serious diseases including stroke, cancer,
diabetes, cataracts, Parkinson's disease, Alzheimer's disease and arthritis
has been questioned in the light of more recent negative research findings
and studies suggesting that antioxidant properties may be absent or reduced
in vivo, may only be important in those with a deficiency or may even be
harmful. (Canter, Wider, & Ernst, 2007)
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Antioxidant is 'any substance that, when present at low concentrations
compared with that of an oxidizable substrate, significantly delays or
inhibits oxidation of that substrate1. This definition includes compounds of
a non-enzymatic as well as an enzymatic nature. Clearly, the diversity of
antioxidants matches that of pro-oxidants (Sies, 1997).
A first line of defense against reactive oxygen species is, of course,
protection against their formation, i.e. prevention. There are numerous
strategies in biology designed to evade oxidative stress, ranging from the
plankton that descends from the surface of the seawater to lower levels of
solar irradiation, to the packaging of DNA in chromatin to shield the
genetic material by providing alternative targets. Microbes have developed
specialized strategies to prevent oxygen- dependent killing by phagocytes.
There are many enzymatic systems in cells and body fluids to control the
level of reactive species which otherwise might generate a cascade of
products which, in turn, would lead to attacking oxidants (Sies, 1997).
Nitric oxide
The role of nitrous oxide in regulating vascular tone, superoxide in
fibroblast proliferation and hydrogen peroxide in the transcription of
cytokines IL-2 and TNF-alpha. During inflammation, oxidation modifies
low-density lipoproteins, inactivates Alpha-1-protease inhibitor, damages
DNA and causes lipid peroxidation. Reactive oxygen species also damage
cartilage and the extracellular matrix and inhibit collagen and proteoglycan
synthesis. (Canter, et al., 2007).
(Moncada & Higgs, 2006),by 1987 it had become apparent that the
generation of NO was not only taking place in the vascular wall, but was
probably a widespread mechanism with far-reaching biological
significance. NO pathway in the central nervous system, where we then
identified the NO syntheses and determined its dependency on
calcium, In the late 1980s, NO was identified as the inhibitory mediator of
nonadrenergic, noncholinergic (NANC) neurotransmission
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in peripheral nerves. This 'nitrergic' neurotransmission has been
demonstrated in the gastrointestinal tract where it is responsible for NANC-
mediated relaxations of the gastric fundus, in the corpus cavernosum where
it brings about relaxation of this tissue, resulting in penile erection, and in
the trachea and the bladder where it contributes to NANC induced
relaxation, nitric oxide (NO), a multifunctional small radical molecule, is
involving in a number of regulatory mechanisms, including vasodilatation,
neurotransmession and nueromodulation, inhibition of platelet aggregation
and modulation of leukocyte adhesion, on the basis of the growing
evidence for the biological importance of NO and the L-arginine-NO
pathway in neural and vasoregulatory mechanisms of the brain. (N.
Bitterman & Bitterman, 1998)
Dietary Antioxidants.
The effect of dietary intake of the antioxidants ascorbate,tocopherol, and
carotenoids is difficult to disentangle by epidemiological studies from other
important vitamins and ingredients in fruits and vegetables. Nevertheless,
several arguments suggest that the antioxidant content of fruits and
vegetables is a major contributor to their protective effect, (i) Biochemical
data, discussed above, show that oxidative damage is massive and is likely
to be the major endogenous damage to DNA, proteins, and lipids. (ii)
Oxidative damage to sperm DNA is increased when dietary ascorbate is
insufficient, (iii) Epidemiological studies and intervention trials on
prevention of cancer and cardiovascular disease in people taking
antioxidant supplements are suggestive, though larger studies need to be
done. Small-molecule dietary antioxidants such as vitamin C (ascorbate),
vitamin E (tocopherol), and carotenoids have generated particular interest
as anticarcinogens and as defenses against degenerative diseases. Most
carotenoids have antioxidant activity, particularly against singlet oxygen,
and many, including BetaAcarotene, can be metabolized to vitamin A
(retinal). Earlier papers have called attention to a number of previously
neglected physiological antioxidants, including urate, bilirubin, carnosine,
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and ubiquinol. Ubiquinone (CoQlo), for example, is the critical small
molecule for transporting electrons in mitochondria for the generation of
energy. Its reduced form, ubiquinol, is an effective antioxidant in
membranes. Optimal levels of dietary ubiquinone/ubiquinol could be of
importance in many of the degenerative diseases.(Ames, et al., 1993)
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3.2.3 Basic Aspects Of Stroke
STROKE
Definition of stroke
Stroke was defined according to the World Health Organization (WHO),
criteria as rapidly developed clinical signs of focal disturbance of cerebral
function, lasting for 24 h, or leading to death, with no other apparent cause
than cerebrovascular disease. (Abo K, 1980)
The term stroke denotes a sudden event in which a disturbance of CNS
function occurs due to vascular disease, the annual incidence of stroke is 2
per 1000 of the general population in UK, but is much commoner in the
elderly. These events can be classified clinically into completed strokes,
evolving storks, or transient ischemic attacks in which the CNS disturbance
lasts for less than 24 hours. Transient ischemic attack is a major risk factor
for cerebral infarction; most attacks are due to circulatory changes in the
CNS occurring as the result of disease in the heart or extracranial arteries.
The clinical features of stroke depend on the localization and nature of the
lesion. (J.C.E.UNDERWOOD, 1992)
The consequence of stroke can be understood in the context of the
international classification model; in this model health condition represents
both healthy body systems and disorders or disease. This concept includes
the damage that occurs in the brain tissue as a result on an ischemic
blockage or hemorrhagic stroke, as well as other co morbidities. This
damage often affects performance at the level of body function and
structures in the ICF model, including motor weakness in hemi paretic
pattern, hyper tonicity, impaired motor control, sensory loss, decreased
cognition, and the effects of de conditioning. (Kluding & Gajewski, 2009).
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Epidemiology of stroke and TIA:
Stoke is the second most common cause of death worldwide and major
cause of long-term disability, with a great impact on public health.
Increasing age, hypertension, cigarette smoking, alcohol abuse, diabetes
mellitus, hypercholesterolemia, and history of coronary heart disease,
which contributes in to the risk of stork. M&M, particularly in older
people, with an estimated incidence rate of 3-5 per 1000 in those aged 45-
84 years (McManus, Craig, McAlpine, Langhorne, & Ellis, 2009) (Mitsios,
et al., 2006).
According to the European Scientific Community About one million
strokes occur each year in the European Union. Indeed, about 25% of men
and 20% of women can expect to suffer a stroke if they live to be 85 years
old. As a cause of death worldwide, stroke is second only to coronary heart
disease. Although stroke is a major cause of death, mortality data
underestimate its true burden. This is chronic disability. Since stroke causes
disability more often than death, stroke patients frequently require long
hospital stays followed by ongoing support in the community, or nursing
home care. Stroke is consequently a major drain on health care funding.
Stroke is the number one cause of disability in the European
Union.(Meairs, et al., 2006).
Traumatic brain injury (TBI) is one of the most disabling injuries in the
population, with 1.5 million American's new case each year and 5.3 million
Americans overall requiring long term daily care as a result of their injuries
(Spaethling, Klein, Singh, & Meaney, 2008). Early impairment of cerebral
blood flow in patients with severe head injury correlates with poor brain
tissue O delivery and may be an important cause of ischemic brain damage
(Menzel, et al., 1999)
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Strokes Categories
Stroke can be categories into 4 basic stroke types (D.Hill, 2008):
Ischemia (Ischemic stroke and transient ischemic attack 85% of all
strokes).
Intercerebral hemorrhage (7%-8% of all strokes)
Subarchnoid stroke (7%-8% of all strokes).
Cerebral venous sinus thrombosis («1% of all strokes).
In turn of each these stroke have common risk factors which are (DM,
Hypertension, smoking)Which in generally they underline many storks.
The Trail of ORG 10172 in Acute Stroke Treatment (TOAST),
classification system is typical used in categorized ischemic stroke into
larger artery disease cardio embolic stroke, Lacunar disease, and others.
Risk factors: (Jain, 2004)
Various risk factors for stroke are:
4 Aging
4- Alcohol
4- Atherosclerosis involving major vessels
Atherosclerosis involving aortic arch
4- Carotid stenosis
4* Cardiovascular disease
Heart disease, arterial fibrillation, endocardities, left ventricular
hypertrophy, mitral valve prolapse, myocardial infarction, patent
foramen ovale.
4- Coagulation disorders
4 Cold
•4- Endocrine disorders
4- Diabetes mellitus
4- Hypothyroidism
4^ Female sex
4- Genetic
4- Angiotensin-converting enzyme gene deletion polymorphism
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Genetically determined cardiovascular, hematological and
metabolic disorders causing stroke
Hemorrheological disturbances
Increased blood viscosity, elevated hematocrit, red blood cells
disorders, and leukocytosis.
Heredity; parental history of stroke is associated with increased
stroke risk in the offspring.
Hyperlipidemia
Hypertension
Hypotension
Lack of physical activity
Metabolic disorders; hyperuricemia, hyperhomocysteinemia
Migraine
Nutritional disorders; high salt intake, malnutrition, vitamins
deficiency
Obesity
Psychological factors; anger, aggression, stress.
Pregnancy
Race: strokes more common in black American than whites.
Raised serum fibrinogen levels
Sex: strokes more common in male than female
Sleep related disorders: sleep apnea and snoring.
Smoking
Transient ischemic attacks.
The interaction between risk factors and causes of stroke:(Jain, 2004)
Table 4: Interaction between risk factors and stork (Jain, 2004)
Stages in the Evolution of a Cerebral
Ischemic Episode
I Transient Ischemic Attacks (TIA)
II Reversible Ischemic neurological deficit (RIND)
III Prolonged reversible ischemic neurological deficit
(PRIND) (Stroke in evolution)
IV brain Infarction with fixed Neurological deficit
(complete stroke)
V Chronic post stroke
Minutes to
24h
Hours
Days
Hours to
Months
More than
one year
after onset
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H E M O R R H A G E
There are 2 forms of intrinsic cerebral hemorrhage, primary ICH internal
cerebral hemorrhage, which has a predilection to affect the striatum,
thalamus, midbrain, pons, and cerebellum.
SAH Subarachnoid hemorrhage, which is referred to bleeding beneath the
arachnoids covering of the brain surface and within the contained cisterns.
The most common age is between the fifth and seventh decades of
life.(Frank H. Netter, 2005)
Spontaneous intracerebral hemorrhage
Spontaneous Intercerebral hemorrhage which accounts for 15-20%
of all strokes, has a poor prognosis, paradoxically, hemorrhaged blood is
highly toxic to the brain, most likely because of exposure to free heme
(Iron protoporphyrin IX, a pro-oxidant) liberated from hemoglobin and
other hemoproteins. Because blood is released into extracellular spaces,
and heme cannot be recycled, heme metabolism is critical for the resolution
of ICH. (Wang & Dore, 2007)
Several risk factors play the role in eithopathogenesis of spontaneous
intracerebral hemorrhage (ISCH), the role of DM, is controversial and
contradictory in this field, according to the study which was done in the
Czech Republic, (Olomouc region), the aim was to be able to assess the
role of DM present prior to a hemorrhagic stork in the patients with
(SICH), and to compare it with prevalence in SICH patients to the finding
in general population (as represented by the control group subjects with
low back pain), according to some authors, DM does not rank among its
risk factors. Moreover, a reduced ICH prevalence in diabetic patients was
reported in some papers, they found out 1.5-up to 6-fold lower ICH
occurrence in diabetic, when compared with non-diabetics.
On the other hand, an opposite opinion, considering DM to be a proven as a
risk factor for SICH, at least in young patients aged (18-49 years), can be
also encountered.
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Based on the findings that the researchers in Olomouc they couldn't
confirm the protective effect of DM leading to the SICH prevalence
decrease. This was explained as a possible effect of the specific angiopathy
induced by DM and characterized by a thickening of the basement
membrane of small cerebral vessels and proliferation of the endothelium, as
well as by the increase of platelet aggregability, coagulability and
plasmoinogen activator inhibitors levels, and decrease of the fibrinolytic
activity in DM patients. And the studied concluded that the spinal problem
do not interfere with vascular risk factors. (R.Herzig.I, 2007)
Intracerebral Hemorrhage
Intracerebral hemorrhage is focal bleeding from a blood vessel in
the brain parenchyma. The cause is usually hypertension. Typical
symptoms include focal neurologic deficits, often with abrupt onset of
headache, nausea, and impairment of consciousness. Diagnosis is by CT or
MRI. Treatment includes BP control, supportive measures, and, for some
patients, surgical evacuation (Jones, 2005).
Most intracerebral hemorrhages occur in the basal ganglia, cerebral
lobes, cerebellum, or pons. Intracerebral hemorrhage may also occur in
other parts of the brain stem or in the midbrain.(Frank H. Netter, 2005)
Intracerebral hemorrhage usually results from rupture of an
arteriosclerotic small artery that has been weakened, primarily by chronic
arterial hypertension. Such hemorrhages are usually large, single, and
catastrophic. Use of cocaine or, occasionally, other sympathomimetic drugs
can cause transient severe hypertension leading to hemorrhage. Less often,
intracerebral hemorrhage results from congenital aneurysm, arteriovenous
or other vascular malformation: Vascular Lesions in the brain, trauma,
mycotic aneurysm, brain infarct (hemorrhagic infarction), primary or
metastatic brain tumor, excessive anticoagulation, blood dyscrasia, or a
bleeding or vasculitic disorder.(Frank H. Netter, 2005).
ICH causes infiltration of the brain by blood components that
induce an inflammatory response. (Wang & Dore, 2007)
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Subarachnoid Hemorrhage (SAH)
Subarachnoid hemorrhage is sudden bleeding into the subarachnoid space.
The most common cause of spontaneous bleeding is a ruptured aneurysm.
Symptoms include sudden, severe headache, usually with loss or
impairment of consciousness. Secondary vasospasm (causing focal brain
ischemia), meningismus, and hydrocephalus (causing persistent headache
and obtundation) are common. Diagnosis is by CT or MRJ; if
neuroimaging is normal, diagnosis is by CSF analysis. Treatment is with
supportive measures and neurosurgery or endovascular measures,
preferably in a referral center.(van Gijn & Rinkel, 2001)
Subarachnoid Hemorrhage (SAH), mostly form aneurysms, accounts for
only 3% of all strokes, but for 5% of stroke deaths and for more than one-
quarter of potential life years lost through stroke.(van Gijn & Rinkel,
2001).
The incidence of SAH has remained stable over the last 30 years, in meta-
analysis of relevant studies, the pooledincidence rate was 10.5 per 100 000
person years. There seemed to be a decline over time, but this was caused
by diagnostic bias. That more recent studies reported lower incidence rates
than older studies in which CT is applied to all patients, the incidence is
calculated to be 5.6 per 100 000 patients a year. Gender race and region
have a marked influence on the incidence of SAH, woman have a 1.6 times
[95%confidence interval (CI)] higher risk than men, and black people a 2.1
times (95% CI 1.3-3.6) higher than white men. In Finland and Japan, the
incidence rates are much higher than in other parts of the world, (van Gijn
& Rinkel, 2001)
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B I O M E D I C A L M A R K E R ' S :
Neurons
Neurons or nerve cells vary, considerably in size and appearance within the
CNS. All possess a cell body, and axon and dendrites. The cell body or
perikaryon is easily seen by light microscopy. The perikaryon contains
neurofilaments, microtubules, lysosomes, mitochondria, complex stacks of
rough endoplasmic retinaculum, free ribosome's and a single nucleus with
a prominent nucleolus, some group of neurons contain the pigment
neurolmelanin and are readily identifiable with the naked eye as darkly
colored nuclei such as the one seen in susbstantia niagra. Axon and
dendrite are the neuronal processes, which convey electrical impulses from
and towards the perikaryon respectively. These processes vary enormously
in size and complexity and maybe difficult to identify. Neurons: can
undergo various reactive changes to cell injury(J.C.E.UNDERWOOD,
(1992)).
Injury to the adult central nervous system (CNS) is devastating because of
the inability of central neurons to regenerate correct axonal and dendritic
connections. The consequences of injury are not just breaks in
communication between healthy neurons, but a cascade of events that can
lead to neuronal degeneration and cell death(Horner & Gage, 2000).
As reported by RamoAn y Cajall in 1928, Tello showed in 1911 that adult
CNS neurons could regrow if they were provided access to the permissive
environment of a conditioned sciatic nerve. Seventy years passed before
Aguayo and colleagues replicated these studies with new
methods that definitively confirmed that adult CNS neurons have
regenerative capabilities. This finding revealed that the failure of
CNS neurons to regenerate was not an intrinsic deficit of the
neuron, but rather a characteristic feature of the damaged environment
that either did not support or prevented regeneration.(Horner & Gage,
2000)
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HEMOGLOBIN
The heme proteins myoglobin and hemoglobin maintain a supply of
oxygen essential for oxidative metabolism, myoglobin, a monomeric
protein of red muscle, Stores oxygen as a reserve against oxygen
deprivation. Hemoglobin, a tetrameric protein of erythrocytes, Transports
O2 to the tissues and returns CO2 and protons to the lungs. Cyanide and
carbon monoxide kill because they disrupt the physiologic function of the
heme proteins cytochrome oxidase and hemoglobin, respectively. The
secondary-tertiary structure of the subunits of hemoglobin resembles
myoglobin. However, the tetrameric structure of hemoglobin permits
cooperative interactions that are central to its function. (Murray, 2000 ).
Hemoglobin actively regulates oxygen transport through the oxygen-
hemoglobin (oxyhemoglobin) dissociation curve which describes the
relation between oxygen saturation or content of hemoglobin and oxygen
tension at equilibrium, Haldane effect, results from the fact that the
combination of oxygen with hemoglobin causes it to become a stronger
acid, this displaces CO2 from the blood by 2 ways: when there is more
acid, hemoglobin has less of a tendency to combine with CO2 to form
carbhemoglobin. Increased acidity of the hemoglobin causes it to release an
excess H+ ions and these, in turn bin with bicarbonate ion to form carbonic
acid, which then dissociates into water and CO2, which released from the
blood into the alveoli. (Jain, 2004)
Figure 12: Heme (Murray, 2000 )
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Legend:
Heme. The pyrrole rings and methylene bridge carbons are coplanar,
and the iron atom (Fe2+) resides in almost the same plane. The fifth
and sixth coordination positions of Fe2+are directed perpendicular
to—and directly above and below—the plane of the heme ring.
Observe the nature of the substituent groups on the pcarbons of the
pyrrole rings, the central iron atom, and the location of the polar side
of the heme ring (at about 7 o'clock) that faces the surface of the
myoglobin molecule. (Murray, 2000 )
BBB
The BBB; (Blood brain barrier), depends on the unique
characteristics of the brain capillaries. Continuous tight junctions join the
endothelial cells of brain capillaries. In addition, most brain capillaries are
completely surrounded by a basement membrane and by the processes of
supporting cells of the brain, called astrocytes.
The BBB permits passage of essential substances while excluding unwanted
materials. Reverse transport systems remove materials from the brain.
Large molecules such as proteins and peptides are largely excluded from
crossing the blood-brain barrier. Acute cerebral lesions, such as trauma and
infection, increase the permeability of the blood-brain barrier and alter
brain concentrations of proteins, water, and electrolytes. Due to its unique
structure, the blood-brain barrier (BBB) is capable of limiting the
penetration of a variety of substances from the blood into the brain. The
BBB plays an important role in the homeostasis and is generally seen as a
defense mechanism that protects the brain against various molecules that
may enter the BBB. The BBB is composed of endothelial cells, which form
a diffusion barrier, due to the presence of tight junctions that firmly connect
endothelial cells. Due to the development of small molecular weight tracers
that enter the damaged BBB, disruption was found to be associated with
various neurological disorders such as migraine, post concussion syndrome,
multiple sclerosis and epilepsy. BBB disruption has been shown both in
human as well as in animal studies (van Vliet, et al., 2007)
Moreover, Friedman and colleagues showed that focal opening of the BBB
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by direct cortical application of albumin-containing solution can lead to the
generation of an epileptic focus in rats
Leakage of the blood-brain barrier (BBB) is associated with various
neurological disorders, including temporal lobe epilepsy (TLE). However,
it is not known whether alterations of the BBB occur during
epileptogenesis and whether this can affect progression of epilepsy.(van
Vliet, et al., 2007)
Cerebrospinal Fluid-Brain Barrier (CSF)
The ependymal cells covering the choroid plexus are linked together by
tight junctions, forming a blood-CSF barrier to diffusion of many
molecules from the blood plasma of choroid plexus capillaries to the CSF.
Water is transported through the choroid epithelial cells by osmosis.
Oxygen and carbon dioxide move into the CSF by diffusion, resulting in
partial pressures roughly equal to those of plasma. The high sodium and
low potassium contents of the CSF are actively regulated and kept
relatively constant. (Jain, 2004)
The consequences of cerebral ischemia on the structure and function of the
brain depend largely on the degree and duration of reduced CBF. In rodent
models, a 20-30% decrease in CBF results in decreased protein synthesis.
A 50% decrease in CBF results in increased lactate production and
concomitant glutamate increase. When CBF reaches 20% of its normal rate,
brain cells begin to lose their ionic gradients and undergo depolarization,
which coincides with irreversible neuronal damage (H. Shi & Liu, 2007)
C A R D I O G E N I C FACTORS
Several type of cardiac disease leads to cerebral embolism; cardiac
arrhythmias, ischemic heart disease, valvular disease, dilated
cardiomyopathies, arterial septal abnormalities and intracardic rumors.
Cardiac arrhythmias include chronic and paroxysmal arterial
fibrillation (AF) and sick sinus syndrome (in particular Brady tachycardia
syndrome). Are the most embologenic rhythms. Often, stroke is first sign of
(AF). Because this arrhythmia is often intermittent.
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Patent foramen ovale (PFO) and atrial septal aneurysm are risk
factor for stroke.(Frank H. Netter, 2005)
Table 5: A meta-analysis of Patent foramen ovale (Jones, 2005)
A meta-analysis of case control studies comparing younger patient
(younger than 55 years) o ischemic stroke and non-stroke control patients
showed an odds ration for stroke of 3.1 for PFO (Patentforamen ovale)
And have 6.1 for atrial septal aneurysm. Potential mechanisms for stroke
included paradoxical embolism, direct embolization from thrombi formed
within the (PFO) or atrial septal aneurysm, and thrombus formation caused
by atrial rhythmias thought to be more prevalent in this population. (Jones,
2005)
Atrial myxomas, although rare, are important cause of embolic
strokes. These tumor emboli frequently affect the vasa vasorum lading to
the development of multiple and peripheral cerebral aneurysms similar to
mycotic aneurysms. (Frank H. Netter, 2005)
Large artery occlusive disease
Atherosclerosis causes stenosis or occlusion of the extracranial and
intracranial arteries and is directly responsible for a significant percentage
of cerebral ischemic events. Atheroma formation involves the progressive
deposition of fatty materials and fibrous tissue in the subintimal layer of the
large and medium arteries, occurring most frequently at branching points.
Intraplaque hemorrhage, subintimal necrosis with ulcer formation,
and calcium deposition can cause enlargement of the atherosclerotic plaque
with consequent worsening of the degree of arterial narrowing. This
disruption of the endothelial surface triggers thrombus formation within the
arterial lumen, due to the activation of nearby platelets by the sub
endothelial collagen. (Frank H. Netter, 2005)
(Lacunes) Stroke
Lipohyalinosis and fibrinoid necrosis affecting the small arteries are
the anatomic substrate of small vessels disease. Occlusion of these arteries
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causes small (1-20 mm), discrete, and often-irregular lesions called lacunes
to develop. Lacunes occur most often in the basal ganglia, thalamus, pons,
internal capsule, and cerebral white matter. Arterial hypertension and
diabetes are the main risk factor, lacunar stroke maybe embolic (5-7),
cardiombolic stroke may include mural thrombus after myocardial
infarction, atrial fibrillation, valvular heart disease, and aortic arch
ateroembolism. (Frank H. Netter, 2005)
THE ABCD AND ABCD2 SCORES IN TIA PATIENTS
Several validate risk scores exist for long-term risk of stroke following
TIA, the medium risk and more, recently, the short-term risk. The ABCD
score (age, blood pressure, clinical features, duration) was derived to
predict the risk of stroke at 7 days and was validated in several independent
cohorts including a population-based cohort of patient with TIA in Oxford
Vascular Study (OXVASC). And the ABCD2 score refined the ABCD
score, by adding a point to DM, in order to best predict the risk of stroke in
the first 48h. (Koton & Rothwell, 2007)
According to the studies which were done by (Koton & Rothwell, 2007), a
which they studied the association between ABCD and ABCD2 scores, the
presence of D 50% ipsilateral carotid stenosis, or AF ( Arterial fibrillation),
and risk of stroke at 7 days. Their result were, done and among 285 TIA
patients (from 559 referrals of possible TIA), 69 (24%) had either D 50%
carotid stenosis (n=29) or AF (n=42), or both (n=2).
E N D O T H E L I A L AND ITS L I N K TO P A T H O G E N E T I C OF
A T H E R O S C L E R O S I S
The endothelium is a crucial vascular structure not only because it serves as
a barrier between flowing blood and vascular wall but also because it
produces mediators regulating vascular growth platelet function and
coagulation. In addition, it alerts vasomotor tone by synthesizing and
metabolizing vasoactive substances including an endothelium- derived
hyperpolarizing factor, prostacyclin, and most notably, endothelium-
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derived relaxing factor (EDRF), which has been identified as a nitric oxide
(NO) or a related compound. There is nothing new in the notion that
endothelium is central to the pathogenesis of atherosclerosis; how ever the
old assumption that endothelial desquamation precedes lesion development
has given way to the concept of dysfunction of the endothelium since even
advanced lesions may be covered by intact, albeit morphologically alerted,
endothelial cell layers. (Zeiher, 1996)
In general recognized that endothelium produces a number of substances
that can modulate local platelet adhesion and aggregation antiplatelet
pavacine substances includes two compound's that are also vasodilators.
These prostacyclin (PGI2) and endothelium derived relaxing factor nitric
oxide (EDRF/NO). Tissue beneath the endothelium "Subendothelium"
contains collagen fibrils. In early 1960s, it was established that such
collagen could cause platelets adhesion and aggregation in vivo.
It is now well known that shear can activate platelets perhaps by up
regulation important proaggregant molecules on the surface of platelets.
There is a potential clinical importance of modest, non denuding
endothelial damage in encouraging local adhesion/aggregation, specially
where passing platelets may already have been activated by up streams
events, such events occur in coronary disease and in diabetes, activated or
hyperaggregable platelets are also found between transient ischemic attacks
and after complete ischemic stroke.(Rosenblum, 1997)
Endothelial cells produce NO by activation of endothelial nitric oxide
eNOS. Nitric oxide is a double-edge sword in cerebral ischemia and
reperfusion: it can be both protective and deleterious, depending on where
and when it is generated. Immediately after brain ischemia, NO release
from eNOS is protective mainly by promoting vasodilatations.(H. Shi &
Liu, 2007)
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A T H E R O S C L E R O S I S
Atherosclerosis is the leading cause of death in Western society, several
lines of evidence suggest that oxidized lipoprotein play an important role in
the etiology of this disease, Oxidized LDL (low-density lipoprotein), is a
powerful atherogenic agent that is able to bypass the normal feedback-
regulated cellular cholesterol uptake by peripheral cells and lead to foam
cell production, Oxidized LDLs potentate monocyte-endothelial cell
interaction, regulate cytokine expression and stimulate chemotactic factor
expression, they have also been shown to induce apoptosis in vascular
cells. (Kudchodkar, et al., 2000)
The development of atherosclerosis is strongly associated with
dysplidaemia is related to aortic atherosclerosis detected by
transoesophageal echocardiography which have been regarded as important
predictors of ischemic stroke, although these atherosclerotic plaques have
been reported to be sources of cerebral emboli, particularly when they are >
4mm in thickness, the relation of atherosclerosis plaques to different
subtypes of ischemic stroke remains undetermined (Matsumura, et al.,
2002)
Atherosclerosis is being viewed as an inflammatory disease, the metabolic
stress imposed on the endothelium itself seem to recruit inflammatory cells
into the atherosclerotic vascular wall via stimulation of redox sensitive
genes. (Zeiher, 1996)
The arterial wall is composed of a highly ordered structure of cells and
extracellular matrix (ECM). In the intimal layer, endothelial cells sit upon a
basement membrane rich in laminin, fibronectin and type IV collagen. In
the media, individual smooth muscle cells (SMCs) are surrounded by a
basement membrane, and are in turn embedded in fibrillar types I, III and V
collagen, type XVIII collagen,
Fibronectin and proteoglycans. In elastic arteries, each layer of SMCs is
separated by a well-defined, fenestrated elastic lamina. The outermost
layer, the adventitia, is rich in fibroblasts, collagen types I and III and
elastin. After arterial injury and during atherosclerotic plaque development,
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there are pronounced changes in the composition of the ECM. A collagen
molecule in the initiation and progression of atherosclerosis is expanding at
an increasing rate. Once thought to be biologically inert, collagens are now
known to be bioactive components of the ECM, which interact with and
exert profound effects on many cell types within the vessel wall. Moreover,
it has become evident that these effects are heavily dependent on the
geometric organization of collagen molecules within the ECM(Zeiher,
1996)
Yet despite their strength, collagens are highly vulnerable to proteolytic
digestion, remodeling and mineralization, complications which mark
advances in the severity of atherosclerosis and increases in the risk of
detrimental clinical events.(Eser Adiguzel, 2009)
On the basis of epidemiologic data, it has been predicted that each 1
percent reduction in the level of low-density lipoprotein (LDL) cholesterol
results in a reduction of 1.0 to 1.5 percent in the risk of major
cardiovascular events. In trials of LDL-lowering strategies, a reduction of
12 to 38 percent in the LDL level has resulted in a relative reduction in risk
of 19 to 35 percent (Matsumura, et al., 2002)
ATRIAL F I B R I L L A T I O N
Atrial fibrillation is the most common arrhythmia encountered in clinical
practice, accounting for approximately one third of all hospitalizations for
cardiac rhythm disturbances. It has been estimated that 2.2 million
Americans have paroxysmal or persistent AF, but the actual number may
be higher. The prevalence of AF increases with age, reaching as high as 9%
in octogenarians. During the past 20 years, there has been a 66% increase
in hospital admissions for AF due to a combination of factors, including the
aging of the population, a rising prevalence of chronic heart disease, and
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more frequent diagnosis through use of ambulatory monitoring devices.
Atrial fibrillation is associated with an increased risk of stroke, heart
failure, and all-cause mortality, especially in women. The mortality rate of
patients with AF is higher than that of patients in normal sinus rhythm and
is linked to severity of underlying heart disease. The guidelines for
management of patients with AF recommend as a Class I indication that
antithrombotic therapy for patients with atrial flutter follows the same
approach as for patients with AF, given the evidence of their comparable
risk of thromboembolism. Accordingly, these performance measures also
apply to patients with atrial flutter who do not have valvular heart disease.
Given the morbidity, mortality, and costs associated with AF and atrial
flutter, the ACC (American college of cardiology), AHA (American heart
association), and Physician Consortium chose this topic for performance
measures both to raise the level of awareness of current guidelines and to
provide tools physicians can use in practice to improve the quality of care
provided to patients with non-valvular AF and atrial flutter.(Estes, et al.,
2008)
H Y P E R T E N S I O N AND DM
Cardiovascular diseases (CVDs) are the major causes of mortality in
persons with diabetes. Hypertension is approximately twice as frequent in
patients with diabetes compared with patients without the disease.
Conversely, recent data suggest that hypertensive persons are more
predisposed to the development of diabetes than are normotensive persons.
Furthermore, up to 75% of CVD in diabetes may be attributable to
hypertension, leading to recommendations for more aggressive treatment
(i.e., reducing blood pressure to < 130/85 mm Hg) in persons with
coexistent diabetes and hypertension. Other important risk factors for CVD
in these patients include the following: obesity, atherosclerosis,
dyslipidemia, microalbuminuria, endothelial dysfunction, platelet
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hyperaggregability, coagulation abnormalities, and "diabetic
cardiomyopathy." The cardiomyopathy associated with diabetes is a unique
myopathic state that appears to be independent of
macrovascular/microvascular disease and contributes significantly to CVD
morbidity and mortality in diabetic patients, especially those with
coexistent hypertension. This update reviews the current knowledge
regarding these risk factors and their treatment, with special emphasis on
the cardio metabolic syndrome, hypertension, microalbuminuria, and
diabetic cardiomyopathy. This update also examines the role of the renin-
angiotensin system in the increased risk for CVD in diabetic patients and
the impact of interrupting this system on the development of clinical
diabetes as well as CVD.(Sowers, Epstein, & Frohlich, 2001)
Further more regarding the DM hypertension and Atherosclerosis since
they come hand in hand. Studies of atherosclerotic coronary arteries from
diabetic patients have uncovered increased expression of the mRNAs for
types I and III collagen correlated with markers of cell proliferation
including
Cdks and cyclins. These results are interesting because compared to non-
diabetic patients with atherosclerosis, diabetics experience marked
enhancement of vascular collagen accumulation, modification of collagens
by advanced glycation end products, and an increased incidence of
restenosis. Thus, collagen remodeling may be linked to the increased
severity of disease in diabetics.(Eser Adiguzel, 2009)
(RTPA, TPA, OR, PLAT)AND A S P I R I N AS FIRST I N T A K E ON
THE ONSET OF STROKE
More than ten years after its approval of (rtPA) recombinant tissue
plasminogen activator, is still the only one approved therapy for acute
ischemic stroke (AIS). Despite its potential, only 1-2% of all stroke patients
receive rtPA, among the major problems are that relatively few candidate
present within the window, and meet the clinical criteria. Stroke physicians
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are frequently confronted with stroke patients who awaken with a deficit, or
unable to provide the required information's due to aphasia or
disorientation, at present, such patients are excluded from thrombolytic
therapy, even if a CT-Scan is normal or has only minor ischemic changes.
(Kohrmann, Juttler, Hutrner, Nowe, & Schellinger, 2007).
There is a question that we might wonder since the trPA is applied to
certain criteria of patients? Aspirin in a daily dose f 160 to 300 mg,
initiated within 48 h of symptoms onset results in a net decrease in
morbidity and mortality cause by acute ischemic stroke. (Strength of
recommendation) SOR; A based on systemic review, regardless of
availability of CT-Scan. (SOR: A based on meta-analysis). Aspirin is as
effective as anticoagulants in this regard and causes less harm (SOR: A,
based on a systemic review), but it should not be used in patients receiving
thrombolytic therapy. Ibuprofen (Motrin) may decrease aspirin's
effectiveness in acute ischemic stroke. (SOR: C, based on expert opinion)
(Park, Smith, Wanserski, & Neher, 2009).
The Cochrane review confirmed that findings of a previous meta-analysis
of the 1ST (International Stroke Trails) and CAST (Chinese Acute Stroke
Trail). This meta-analysis included subgroup analyses, which found no
difference in effect of treatment based on time from onset of symptoms
(zero to 48 hours), age, sex, level of consciousness, history of AF, heparin
administration, CT findings, or previous CT-Scanning. Patients with a
hemorrhagic stroke who were inadvertently randomized did not appear to
be harmed by aspirin (16% death or further stroke compared with 18% for
the control group). A double-blind, randomized, placebo-controlled trail of
441 patients evaluated the effects of aspiring 325 mg daily for five days on
progression of acute ischemic stroke compare with placebo. Aspirin didn't
affect stroke progression during the treatment period, Its been
recommended by the American Heart Association and the American Stroke
Association Stroke Council recommended an initial aspirin dose of 325 mg
within 24 to 48 hours of the onset of symptoms; however, not within 24
hours of thrombolytic therapy. The American College of Chest Physicians
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recommended a recommended aspirin 160 mg to 325 mg daily started
within 48 hours in patients not receiving thrombolytic therapy. (Park, et al.,
2009)
M O L E C U L A R P A T H O P H Y S I O L O G Y OF ACUTE I S C H E M I C
STROKE
As we were mentioned earlier there is risks that contribute with stroke, the
majority of strokes are cerebral ischemic infarction produced as a result of
atherothrombosis or cardiac and artery- to artery embolism leading to
sudden cessation of cerebral blood flow and oxygen-glucose deprivation in
the corresponding vascular territory, and in every neurons die within the
ischemic core tissue, while the majority of neurons survive for a slightly
longer time in the surrounding penumbra. Cells at the infracted core are
vulnerable and may die within minutes of ischemic onset; however,
different brain areas have varying susceptibilities' to ischaemia and cell
survival largely depends on the severity and duration of the ischemic
incident.(Mitsios, et al., 2006), Acute ischemic stroke results in
heterogeneous changes in cerebral blood flow and brain metabolism in the
affected region. Ischemic penumbra is the initially viable tissue
compromised by partially decreased cerebral blood flow and disturbed
metabolism surrounding the severely damaged ischemic core (S. Liu, et al.,
2004)
Cerebral ischemia causes heterogeneous changes in tissue oxygenation and
cellular metabolism, with a region of decreased blood flow, the penumbra,
surrounding a severely damaged ischemic core. Because oxygenation is
central in ischemic neuronal death, it is critical to understand exactly what
actual changes occur in interstitial oxygen tension (pO2) in ischemic
regions during stroke, particularly the penumbra and ischemic core.
Cerebral ischemia induces a complex series of molecular pathways
involving signaling mechanisms, gene transcription, and protein formation.
The final volume of the infracted tissue is determined by the surviving (H.
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Shi & Liu, 2007). Penumbra, a region of potentially viable ischaemic tissue
around the infracted core, where electrical activity is maintained and blood
flow rate (more than 20-25% of regular blood flow) is sufficient for a
certain degree of neuronal function and membrane integrity, with the
degree of neuronal loss being proportional to the degree of cerebral blood
flow reduction . The penumbra includes ischaemic areas that recover
spontaneously and areas that progress to irreversible changes, unless
effective treatment is used. After an ischaemic injury to the brain, the
centre of the core is perfused at 10-12 ml/100 g/min or less while the
ischaemic area around the centre (immediately surrounded by the
penumbra) is critically hypoperfused at less than 18- 20 ml/100 g/min and
is at risk of dying within hours, as the evolving infarction expands. The
penumbra zone immediately surrounded by normal brain tissue is less
likely to die, since it is perfused at a higher rate, although below the
minimal normal rate of approximately 60-ml/100 g/min. There, selective
gene expression and a decrease in protein synthesis are observed while in
the area immediately surrounding the infracted core, perfused at just over
20 ml/100 g/min, lactic acidosis and cytotoxic edema take place.(Mitsios,
et al., 2006)
The ischaemic core suffers an irreversible loss of ion homeostasis while in
the penumbra the insult is either milder or of shorter duration. Neurons in
the penumbra are mostly dysfunctional and unable to maintain full normal
function but can be saved if reperfused in time.
In contrast, if blood flow drops below 10-15 ml/100 g/ min and does not
return to normal, the infarct will expand and neuronal activity will cease. If
the ischaemic state continues for an extended period, primary neuronal
death occurs quickly in the core, with secondary death
developing gradually in the penumbra. (Mitsios, et al., 2006)
In cerebral ischaemia, the obstruction of cerebral blood flow results in a
quick reduction of ATP availability, rapid failure of membrane ionic pumps
and loss of ion homeostasis, release of glutamate, and neuronal calcium
excess that activate a series of detrimental enzymatic cascades. All these
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events occur within 1 or 2 h.(Mitsios, et al., 2006)
While irreversible cell death begins within minutes after stroke onset within
regions of maximally reduced blood flow (the infarct "core"), for several
hours there exists a surrounding "penumbra" of ischemic but non-infracted
tissue that is potentially salvageable
The concept of an "ischemic penumbra" provides a rationale for the use of
neuroprotective drugs and reperfusion techniques to improve outcome after
acute ischemic stroke. Then again, the extent of penumbral tissue is thought
to diminish rapidly with time, hence the therapeutic time window is
narrow(Aneesh B. Singhal, 2006).
Cerebral ischemia manifests itself in two distinctly different pathological
areas in the brain referred to as the ischemic core and penumbra. The
ischemic core is an area that has the greatest reduction in CBF and
undergoes severe irreversible damage. The penumbra is the surrounding
area of the ischemic core and is characterized by reduced CBF and O2
metabolism, but an increased O2-extraction fraction, which reflects an
attempt to maintain oxygen-dependent high energy metabolism (H. Shi &
Liu, 2007)
Penumbra Infracted core MCAO
Figure 13 Cerebral ischemia (Mitsios, etal., 2006)
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Legend:
Cerebral ischaemia results in rapid cell death in the infracted core within the
immediate area of the occluded artery, followed by a less severe infarction in the
penumbra in which cells may die over a period of several hours after the insult.
MCAO - Middle cerebral artery occlusion.(Mitsios, et al., 2006)
I N F L A M M A T I O N
The reduction of cerebral blood flow after stroke elicits a robust
inflammatory response in the injured brain, characterized by inflammatory
gene expression leading to local activation and release of various cytokines,
chemokines, endothelial-leucocyte adhesion molecules and proteolytic
enzymes, which propagate inflammatory signals and exacerbate tissue
damage for several days after the onset of symptoms . Astrocytes,
microglia, leucocytes and endothelial cells (EC) activated by ischaemia
produce cytokines. This has been detected in both experimental models of
stroke and human patients.
There is evidence for cytokines produced by stimulated macrophages and T
cells at the site of the developing cerebral infarction, which then promote
migration of leucocytes from the vascular lumen into the brain tissue and
regulate inflammatory and immune responses.
Pro-inflammatory cytokines are expressed de novo within the first 2 h after
onset of ischaemia and remain elevated for several days after stroke onset,
which reflects the intensity of inflammation and its role in tissue
damage.(Mitsios, et al., 2006)
Both focal and global brain ischaemia is associated with expression of a
number of inflammatory cytokines [interleukin-1 (IL-1) and tumor necrosis
factor- (TNF)] and chemokines [IL-8, monocyte chemoattractant protein-1
(MCP-1), RANTES and IP-10], while up regulation of adhesion molecules
(1CAMI and selectins) induces leucocyte recruitment to the vascular
endothelium which may affect the survival of damaged neurons (Mitsios, et
al., 2006).
Tumor Necrosis Factor Alpha
TNF: A cytotoxic monokine produced by macrophages stimulated with
bacterial endotoxin, TNF alpha, participates in inflammation, wound
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healing, and remodeling of tissue, its also called CACHECIN, it was named
because of its ability to induce wasting and anemia when administered on a
chronic basis to experimental animals. It can induce septic shock and
cachexia. It is a cytokine comprised of 157 amin acid residues, it produced
by numerous types of cells including monocytes, macrophages, T
lymphocytes, B lymphocytes, NK cells and other types of cells stimulated
by endotoxin or other microbial products (Julius M. Cruse, 1995).
Tumor Necrosis Factor- alpha, TNF plays a significant role in brain
immune and inflammatory responses, allowing leucocyte adhesion and
infiltration into the ischaemic brain. Consequently, agents that suppress
TNF production or its actions reduce leucocyte infiltration into ischaemic
brain and diminish the extent of tissue loss. Furthermore, TNF activates
glial cells, thereby regulating tissue remodeling and scar formation. Anti-
inflammatory interventions that limit the degree of damage interfere with
nerve regeneration and recovery. In animal models of stroke, ischaemia
induces expression of TNF. Increased expression of TNF, mRNA occurs
rapidly after middle cerebral artery occlusion (MCAO) in rats at 1-3 h,
peaking at 6-12 h postischaemia and subsiding 1-2 days later. TNF was
present early in neuronal cells, in infarct and penumbra, and at later time
points in macrophages in the infarct. Some studies demonstrated that the
size of a brain infarct after MCAO in mice was larger in animals
genetically deficient in TNF receptors and the injection of TNF 48 h prior
to the occlusion was neuroprotective. There are only a few studies on local
inflammation and the development of cerebral ischaemia in humans. There
was increased expression of TNF mRNA during the first few hours after
MCAO in most animal models. Likewise, in humans, higher cerebrospinal
fluid (CSF) and serum levels of TNF were in both infarction volume and
mortality, the role of TNF in ischaemic stroke is complex and controversial
and probably depends on experimental conditions; most studies suggest a
neurotoxic function while some consider it to be neuroprotective.
Therefore, a better understanding of TNF downstream observed within the
first 6-12 and 24 h after stroke. Interestingly, TNF suppression in mice 30
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min after stroke induction ameliorated stroke-related damage at two levels,
the primary ischaemic and the secondary inflammatory injury and was
accompanied by a decrease signal transduction mechanisms and gene
regulation in neuro-inflammation could provide several opportunities for
the discovery of novel compounds which may be useful in patients with
stroke (Mitsios, et al., 2006).
Neuropeptide Y
Neuropeptide Y (NPY) modulates immune cell distribution,
T helper cell differentiation and natural killer cell activation. Increased
NPY immunoreactivity within the perilesional cortex following MCAO or
focal excitotoxic damage, in rats has been reported. NPY immunoreactivity
was increased at 6 h in the peri-ischaemic region and peaked at around 3
days, decreasing at 10 days. These results suggest that a survival time of 3
days after focal ischaemia is the critical period for examining the
relationship between NPY responses and functional
recovery. Peripheral or central administration of NPY impairs reperfusion
following MCAO in rat, reduces cerebral blood flow, increases infarct
volume and worsens the outcome of focal cerebral ischaemia (Mitsios, et
al., 2006).
Excitotoxicity and cell damage
Excitotoxicity is the pathological process by which neurons are damaged
and killed by the over activations of receptors for the excitatory
neurotransmitter glutamate, such as the NMDA receptor and AMPA
receptor, glutamate mediates excitotoxic synaptic transmission via
activation of N-methyl- D -aspartate (NMDA), alpha-amino-3-hydroxy-5-
methyl-4-propionate (AMPA) or kainite receptors. When glutamate is
released from pre-synaptic terminals, it allows Na + and Ca 2+ influx that
depolarizes the membrane. While this is vital for neuronal plasticity,
additional activation of receptors results in neuronal death. Glutamate is
released in an uncontrolled manner in ischaemic areas. The glutamate -
calcium cascade induces a necrotic lesion and Ca 2+ -mediated
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excitotoxicity plays an important role in brain infarction. Antagonists of
glutamate receptors, shown to reduce ischaemic injury in animal models,
have been applied in man with little therapeutic beneficial effect. NMDA
receptors are highly permeable to Ca 2+ , Na+ , K + and H + cations. Their
activation is a primary cause of neuronal death after ischaemia that is
accompanied by temporary elevation of extracellular glutamate. Ca 2+
influx mediates NMDA neurotoxicity while Na + influx contributes to
swelling of neuronal cell bodies. Normally the free Ca 2+ concentration in
the cytoplasm is approximately 1/10,000 of its extracellular concentration.
The export of Ca 2+ from neurons into the extracellular environment
occurs via processes that are linked to energy utilization. Energy failure in
the brain during hypoxia results in a passive efflux of K + from cells,
enhancing Ca 2+ entry and release into neurons, the unregulated rise in
intracellular cytoplasmic Ca 2+ links glutamate excitotoxicity to
biochemical processes resulting in further injury, i.e. oxidative stress.
Prolonged elevation of Ca 2+ levels activates Ca 2+ -dependent effectors
proteins and enzymes such as endonucleases, phospholipases, Upases,
protein kinases and proteases that may damage DNA, lipids and proteins.
Identification of the modulators of excitotoxic neuronal death ought to help
the development of new approaches to prevent stroke-induced neurological
dysfunction (Mitsios, et al., 2006).
Synaptosomal-associated protein 25 (SNAP25) is a neuron-specific protein,
primarily localized in nerve endings and axons and involved in synaptic
vesicle exocytosis, axonal outgrowth and transmitter release, SNAP25
immunoreactivity was increased in mossy fibers as early as 2, 4 and 7 days
after ischaemia and subsided on day 15.(Mitsios, et al., 2006).
NMDA receptor antagonists prevent the expansion of stroke lesions in part
by blocking spontaneous and spreading depolarization's of neurons and
glia (cortical spreading depression) (Hossmann, 1996)
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3.2.4 Mechanisms of ischemic cell death
Ischemic stroke compromises blood flow and energy supply to the brain,
which triggers at least five fundamental mechanisms that lead to cell death:
excitotoxicity and ionic imbalance, oxidative/nitrative stress, inflammation,
apoptosis, and peri-infarct depolarization (Aneesh B. Singhal, 2006).
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Figure 14: Major pathways of ischemic cells death (Aneesh B. Singhal, 2006)
Legend:
Major pathways implicated in ischemic cell death: excitotoxicity, ionic
imbalance, oxidative and nitrative stresses, and apoptotic-like mechanisms.
There is extensive interaction and overlap between multiple mediators of
cell injury and cell death. After ischemic onset, loss of energy substrates
leads to mitochondrial dysfunction and the generation of reactive oxygen
species (/?<9S) and reactive nitrogen species (ft/VS).Additionally, energy
deficits lead to ionic imbalance, and excitotoxic glutamate efflux and build
up of intracellular calcium. Downstream pathways ultimately include direct
free radical damage to membrane lipids, cellular proteins, and DNA, as
well as calcium-activated proteases, plus caspase cascades that dismantle a
wide range of homeostatic, reparative, and cytoskeletal proteins.
(Chawla-Sarkar, et al., 2003)
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Ischemic cell death is initiated by changes that result directly from
inhibition of oxidative phosphorylation and create an early maelstrom of
activity. These changes include decreased pH, decreased ATP, initiation of
free radical production by the mitochondrial chain, increased cell Nal and
membrane depolarization as a result of the loss of ATP substrate for the
Nal-Kl pump. These lead to secondary changes in ion and chemical
concentrations which, in concert with the initiating changes, result in
activation of damaging processes. These damaging processes are termed
"perpetrators" in this review and are characterized by their abilities to
produce long-term changes in macromolecules. Activation of one or more
of the perpetrators is considered the key step in necrotic aspects of ischemic
cell death (Lipton, 1999)
APOPTOSIS
A variety of key events in apoptosis focus on mitochondria, including the
release of caspase activators (such as cytochrome c), changes in electron
transport, loss of mitochondrial transmembrane potential, altered cellular
oxidation-reduction, and participation of pro- and antiapoptotic Bcl-2
family proteins. The different signals that converge on mitochondria to
trigger or inhibit these events and their downstream effects delineate
several major pathways in physiological cell death (Green, et al., 1998).
Mitochondria spontaneously released cytochrome c, which activated
DEVD-specific caspases, leading to fodrin cleavage and apoptotic nuclear
morphology. Bcl-2 acted in situ on mitochondria to prevent the release of
cytochrome c and thus caspase activation. During apoptosis in intact cells,
cytochrome c translocation was similarly blocked by Bcl-2 but not by a
caspase inhibitor, zVAD-fmk. In vitro, exogenous cytochrome c bypassed
the inhibitory effect of Bcl-2. Cytochrome c release was unaccompanied by
changes in mitochondrial membrane potential. Thus, Bcl-2 acts to inhibit
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cytochrome c translocation, thereby blocking caspase activation and the
apoptotic process.(Kluck, Bossy-Wetzel, Green, & Newmeyer, 1997).
Apoptosis is the evolutionarily conserved process by which cells die as a
result of an internally programmed series of events mediated by a dedicated
set of gene products and is associated with condensation of the nucleus and
cytoplasm, nuclear fragmentation, and aggregated
condensation of nuclear chromatin, in addition to cell shrinkage, giving
way to the development of apoptotic bodies. (Mitsios, et al., 2006)
Cell death following cerebral ischaemia can be described as either necrotic
or apoptotic by histological criteria. Necrosis is the predominant
mechanism that follows global ischaemia, whereas in milder injury, death
may resemble apoptosis. Indeed, data suggesting that apoptosis contributes
importantly to brain damage after global or focal ischaemia have expanded
within the past 15 years.(Choi, 1996).
Following stroke, there is an early response in gene expression of
molecules such as the Bcl-2 family and p53. Then there is a release of
proapoptotic molecules such as cytochrome c and apoptosis-inducing factor
from mitochondria, leading to activation of caspases and other
genes that augment cell death (Mitsios, et al., 2006)
Despite convergent morphology, it is apparent that apoptosis triggered by
different conditions can occur by disparate molecular mechanisms:
thymocytes from p53 knock-out mice are resistant to apoptosis induced by
radiation, but not by glucocorticoids (Choi, 1996)
p53 and Phosphorylated p53
p53 is expressed in dividing cells following DNA damage; it halts cell
division and permits DNA repair, thus preventing the replication of
damaged DNA. In several other experimental settings, however, p53 is
essential for neuronal death and may participate in neurodegenerative
disorders. p53 induction by oxidative stress/hypoxia results in apoptosis. In
addition to elevating the levels of proteins that mediate release of
cytochrome c, p53-mediated apoptosis also involves binding to anti-
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apoptotic proteins, inhibiting their ability to suppress cytochrome c
release.(Mihara, et al., 2003)
Degeneration and death of neurons in stroke involves apoptotic
biochemical cascades implicating upstream effectors such as p53. Increased
p53 immunostaining has been observed in neurons and glia following focal
cerebral ischaemia in the rat.(Li, et al., 1994)
Bcl-2 expression can rescue ciliary neurons deprived of brain-derived
neurotrophic factor (BDNF), but not ciliary neurotrophic factor
(CNTF)(Choi, 1996).
The Bcl-2 gene family, including anti-apoptotic and pro-apoptotic counter
molecules, is a fundamental gene group in cell death-signaling cascades.
The relative amounts of active anti- and pro-apoptotic Bcl-2 family
proteins determine the sensitivity or resistance of cells to apoptosis. The
chief function of Bcl-2 family proteins is to regulate the release of
cytochrome c and other pro-apoptotic proteins from mitochondria.(Mitsios,
et al., 2006).
Caspase-3 and Active Caspase-3
Activation of caspases by cytochrome c appears to be an integral part of
apoptotic cell death. Caspase-3 can be activated by caspase-8 and caspase-9
and is a well-characterized pro-apoptotic executioner, involved in
proteolytic processes in apoptotic cells.
Biochemical and immunohistochemical studies have demonstrated
expression and activation of caspase-3 after stroke although conflicting
data with respect to the presence of caspase-3 under ischaemic conditions
exist.(Mitsios, et al., 2006).
Neuronal caspase-3 levels increased 16-24 h after permanent MCAO in
rat(Krupinski, Lopez, Marti, & Ferrer, 2000).
Neuronal death induced by hypoxia-ischemia has seemed for years an
open-and-shut case for necrosis Wyllie and colleagues, used hypoxia-
ischemia as an example of a Violent1 environmental perturbation capable of
producing necrosis. The implication of excitotoxicity as an important
component of ischemic neuronal death over the past decade has further
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strengthened this notion, as the central features of excitotoxicity would
seem to epitomize membrane failure and necrosis. Overstimulation of
neuronal glutamate receptors typically leads to rapid, dramatic cell body
and dendrite swelling, mediated by excessive Na + and Ca 2+ entry through
glutamate receptor gated channels, associated with CI- and water
influx(Choi, 1996).
Free radicals play a significant role in cell signaling and the induction and
activation of multiple genes. For example, there is growing evidence that
free radicals influence the action of proteases at multiple levels, including
transcription and processing of mRNA and activation of latent proteases,
induction of hypoxia inducible factor 1, and caspase-involved apoptosis.(H.
Shi & Liu, 2007)
C H A N G E S OF TISSUE OXYGEN AFTER C E R E B R A L I S C H E M I A &
R E P E R F U S I O N
Although the cerebral oxygen level is a critical issue in cerebral ischemia,
monitoring oxygen levels in cerebral tissue in vivo and in real-time remains
very challenging technically, especially in deeper tissue when repetitive
measurements are needed. Several techniques are available that can be used
to measure tissue oxygen, including Clark-type electrodes, fluorescence
quenching, phosphorescence quenching, near infrared spectroscopy, MRI,
and electron paramagnetic resonance (EPR) oximetry. However, each of
these techniques has its own particular advantages and limitations. For
example, Clark-type electrode techniques cause traumatic lesions that do
not heal when the electrode is inserted in to the brain. Optical measuring
techniques for brain tissue pO2 have the limitation of measurement depth
(H. Shi & Liu, 2007)
Neuroprotective
SPECIFIC PROTEINS are expected to be released from neurons and their
processes following central nervous system (CNS) injury and disease. An
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assay that could reliably quantify the levels of these released proteins might
provide useful information about the degree of neuronal injury occurring as
a result of damage and disease states, and would be particularly useful if
such proteins could be detected in blood.(K. J. Anderson, et al., 2008)
Neuroprotection can be defined as the protection of cell bodies and
neuronal and glial processes by strategies that impede the development of
irreversible ischemic injury by effects on the cellular processes involved.
Neuroprotection can be achieved using pharmaceutical or physiological
therapies that directly inhibit the biochemical, metabolic, and cellular
consequences of ischemic injury, or by using indirect approaches such as
t-PA which was mentioned earlier and mechanical devices to restore tissue
perfusion (Aneesh B. Singhal, 2006).
One of the first groups of neuroprotective genes expressed after stroke is
the heat shock protein family (HSPs), which acts to prevent aggregation of
denatured proteins and aid their refolding to the correct tertiary structure.
Its an antibodies of the IgM, IgG classes specific for a 73 kD chaperonin
that belongs to the hsp70 family. (Julius M. Cruse, 1995)
HSP70 is one of the major inducible stress proteins upregulated in response
to ischaemia. Its mRNA is usually expressed within 1-2 h and then down
regulated by 1-2 days. HSP70 may be a marker for neuroprotection in the
early stages of ischaemic stroke and many mechanisms have been
suggested for HSP70 protection from cerebral ischaemia, including defense
against apoptotic and necrotic cell death. (Mitsios, et al., 2006).
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POST-STROKE RISKS " C O M P L I C A T I O N S "
After a stroke patients have several risks factor such as. Recurrent of
vascular events post stroke are well documented and studies have suggested
that rates higher than previously expected; a 5-year stroke recurrence rate
of up to 16% and a cumulative 10-years risk for vascular events of 44.1%
have been quoted. (McManus, et al, 2009)
Patients have a higher risk of experiencing a fall. Falls are one of most
common complications of rehabilitation in the patient's populations.
According to the study which was done in Poland by (Czernuszenko &
Czlonkowska, 2009), the study was done on 1155 patients 56% were men,
the study was from (1-74 days), total of 252 falls were recorded for 189
(16.3%) patients and 45 patients experiences 108 repeated falls. The
incidence of falls was 7.6/1000 patients a days. Falls occurred in 16% of
patients during post-stroke inpatient's rehabilitation, but only 1.2% of falls
(1.6% of patients who fall) result in fractures. Increase risk factor of all
falls is strongly associated with severe baseline stroke-related disability,
short time (<12 weeks) after stroke onset and greater improvement in
functional status during rehabilitation. The study showed a severe risk
related in early period after stroke are prone to falls during rehabilitation,
multiple falls are most frequent in patients over 65 years age.
(Czernuszenko & Czlonkowska, 2009). According to the randomized study
which was done by (McManus, et al., 2009), the study appears to be one of
a small number carried out showing long-term outcomes in post stroke
patients is disappointing, it seems that brief intervention with education and
counseling had no long term benefit on behavior modification or risk factor
control.
(Kluding & Gajewski, 2009) strength deficits in the hemiparetic lower
extremity should be an important target for clinical interventions to
improve function in people with chronic stroke.
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4 Methodology
A D V I S O R Y G R O U P
We identified technical experts to assist us in formulating the research
questions and identifying relevant databases for the literature search. The
expert panelists included a neurologist specializing in stroke, a physician
with an HBOT practice. Throughout the project period, we consulted
individual members on issues that arose in the course of identifying and
reviewing the literature.
Literature Search, Study Selection, and Data
Extraction
We searched a broad range of databases to identify published and
unpublished studies of the effectiveness and harms of HBOT in patients
with brain injury, and stroke, neurological disorders and other internal
disorders
We selected and extracted recent articles from 1962- 2009 that we felt to be
of relevance or interesting as well as choosing topics that we were aware
of being potentially important.
Each database was searched from its starting date to August
2008. The databases searched were:
± MEDLINE®
4 Pre MEDLINE
± EMBASE
4- ProQuest
4- Oxford journal
4~ American heart association
4* Cochrane Database of Systematic Reviews
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4* Cochrane Controlled Trials Register
4- DARE (Database of Abstracts of Reviews of Effectiveness)
4- CINAHL (Cumulative Index to Nursing & Allied Health)
4- MANTIS (Manual, Alternative and Natural Therapy)
4- Health Technology Assessment Database
4- The New England Journal of Medicine
4- The Undersea & Hyperbaric Medical Society: a large bibliographic
database (30,000 records), http://www.uhms.org/library.htm
4- The Database of Randomized Controlled Trials In Hyperbaric
Medicine ,http: //hboe vidence. com/
4- European Underwater and Baromedical Society,
http://www.eubs.org/
4- International Congress on Hyperbaric Medicine,
http://www.ichm.net/
4- TEAG members identified the following additional databases as
potential sources of other material that may not be
indexed in other electronic databases:
4- European Underwater and Baromedical Society
4- International Congress on Hyperbaric Medicine
4^ National Baromedical Services, Inc.
4- Update literature searching of the electronic databases
MEDLINE, PreMEDLINE, EMBASE, CINAHL, the
Cochrane Library, and the Health Technology Assessment
Database was completed on February 26, 2009, using the same
search strategy as used for the initial searches. Eight additional
references submitted by a peer reviewer were added in March
2009.
The references of all included papers were hand searched. In
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addition, we review independently and conducted hand searches
of the references from the (Eric P. Kindwall, (September 3, 2004); Frank H.
Netter, 2005; J.C.E.UNDERWOOD, (1992); Jain, 2004) We reviewed as
well exclude independently and assessed each title and abstract located
through the literature searches for relevance to the review, based on the
intervention, population, outcome, and study design criteria. The full-text
articles, reports, or meeting abstracts that met the criteria listed above were
retrieved and reviewed independently by one reviewer who reapplied the
eligibility criteria. Disagreements were resolved through consensus. One
reviewer performed extraction of data from studies.
SCOPE
To identify the patient groups, interventions, and outcomes that should be
included in the review, we read background material from diverse sources
including textbooks, government reports, proceedings of scientific
meetings, and Web sites. We also conducted focus group and interviews to
improve our understanding of the clinical logic underlying the rationale for
the use of HBOT. In the focus group, we identified outcomes of treatment
with HBOT that are important to patients and examined whether patients,
who have experience with HBOT value certain outcomes differently. A
broader goal of the focus was to better understand the main
pathophysiologic reactions that brain cells undergo during ischemic brain
attack. And the free radicals in the human body specifically in
mitochondria. By reviewing the fundamentals of stroke we aim to achieve a
clear view on the subject in order to recognize the therapeutic specificity
that hyperbaric oxygen therapy (HBOT) offers. We also took a closer look
on the basics of HBO, its history, physiological aspects, indications, the
principals that accompany it.
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V A L I D I T Y OF E V I D E N C E OF THE DATA
The analyses of individual studies reviewed for quality and consistent
evidence for each key question is based on the sufficient Evidence ,
Validity of the information also regarded Author's opinion and advices
due to there experience's in the case of the hyperbaric oxygenation we also
included arguments of these authors about hyperbaric oxygenation and
oxidative stress. The quality of all trials in the review was assessed using a
list of items indicating components of internal validity. We modified the
standard checklists to address issues of particular importance in studies of
HBOT. For randomized controlled trials (RCTs) and nonrandomized
controlled trials (NRCTs),
Each study was assigned an overall rating (good, fair or poor) according to
the US Preventive Services Task Force methods.
Good:
Comparable groups assembled initially (adequate randomization and
concealment, and potential confounders distributed equally among groups)
and maintained throughout the study; follow up at least 80 percent; reliable
and valid measurement instruments applied equally to the groups; outcome
assessment masked; interventions defined clearly; all important outcomes
considered; appropriate attention to confounders in analysis; for RCTs,
intention-to-treat analysis.
Fair:
Generally comparable groups assembled initially (inadequate or unstated
randomization and concealment methods) but some question remains
whether some (although not major) differences occurred with follow-up;
measurement instruments acceptable (although not the best) and generally
applied equally; outcome assessment masked; some, but not all important
outcomes considered; appropriate attention to some, but not all potential
confounders; for RCTs, intention-to-treat analysis.
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Poor:
Groups assembled initially not close to being comparable or not maintained
throughout the study; measurement instruments unreliable or invalid or not
applied equally among groups; oolcome assessment not masked; key
confounders given little or no attention; for RCTs, no intention-to-treat
analysis.
The discussion of results and conclusions in this report is based on the
analysis of information extracted from the above mentioned text books as
well as good- and fair-quality studies. Results of good-quality studies have
a high likelihood of being both valid and reliable. Fair-quality studies have
important but not fatal flaws in their design or conduct. The category of fair
is broad, with some studies that are probably valid and others that are
unlikely to be valid, depending on the specific flaws found and their
severity. The inadequacies found in poor-quality studies make the results
unreliable.
DATA EXTRACTION SYNTHESIS
We extracted data from literatures, articles and studies which is in the point
of the aims of this work and critically reviewed to be afterward synthesized
to draw together a symmetrical line in the thesis review to meet the aims
and the Scope and Key questions, an analysis of whether the body of
evidence is sufficient to provide a clear answer to the key questions' was
looked.
Evidence
The analyses of individual studies reviewed for quality and consistent
evidence for each key question is based on the internal and external
validity. An analysis of whether the body of evidence is sufficient to
provide a clear answer to the key questions was undertaken.
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5 The analyses of Data and Discussion
Findings
Brain Injury
For traumatic brain injury, some trial studies were provided fair evidence
that HBOT might reduce mortality or the duration of coma in severely
injured TBI (traumatic brain injuries) patients. However, HBOT also
increased the chance of a poor functional outcome. (G. L. Rockswold &
Ford, 1985; G. L. Rockswold, Ford, Anderson, Bergman, & Sherman,
1992; S. B. Rockswold, et al., 2007)
The quality of the controlled trials was fair, meaning that deficiencies in the
design add to uncertainty about the validity of results.
(Lin, et al., 2008) did a study group randomly included 22 patients who
received HBOT after the patients' condition stabilization, and the other 22
corresponding condition patients were assigned into the matched control
group who were not treated with HBOT. The clinical conditions of the
patients were evaluated with the Glasgow Coma Scale (GCS) and Glasgow
Outcome Scale (COS) before and 3 to 6 months after HBOT. The GCS of
the HBOT group was improved from 11.1 to 13.5 in average, and from
10.4 to 11.5 (p < 0.05) for control group. Among those patients with GOS
= 4 before the HBOT, significant GOS improvement was observed in the
HBOT group 6 months after HBOT. Based on this study, HBOT can
provide some benefits for the subacute TBI patients with minimal adverse
side effects.
[Palzur and colleague's (Palzur, Zaaroor, Vlodavsky, Milman, & Soustiel,
2008)] their recent experimental data have shown that hyperbaric oxygen
therapy (HBOT) was associated increased Bcl-2 expression at the injury
site that correlated with reduced apoptosis. We hypothesized that HBOT
mediated enhancement of Bcl-2 expression and increased intracellular
oxygen bioavailability may both contribute to preserve mitochondrial
integrity and reduce the activation of the mitochondrial pathway of
apoptosis. For this purpose, a cortical lesion was created in the parietal
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cortex of Sprague-Dawley rats by dynamic cortical deformation (DCD) and
outcome measures in non-treated animals were compared with that of
HBOT treated rats. Morphological analysis showed a profound reduction in
neuronal counts in the perilesional area and a marked rarefaction of the
density of the axonal-dendritic network. In treated animals, however, there
was a significant attenuation of the impact of DCD over perilesional
neurons, characterized by significantly higher cell counts and denser axonal
network. In mitochondria isolated from injured brain tissue, there was a
profound loss of mitochondrial transmembrane potential (Deltapsi(M))
that proved to be substantially reversed by HBOT. This finding correlated
with a significant reduction of caspases 3 and 9 activation in HBOT treated
animals but not of caspase 8, indicating a selective effect over the intrinsic
pathway of apoptosis. All together, our results indicate that the
neuroprotective effect of HBOT may represent the consequence of
preserved mitochondrial integrity and subsequent inhibition of
the mPTP and reduction of the mitochondrial pathway of apoptosis.
[Shi and colleagues (X. Y. Shi, et al., 2006)] studied three hundred and ten
patients with neuropsychiatric disorders arising from traumatic brain injury
were treated twice with hyperbaric oxygen. Cerebral single photon
emissions computed tomography (SPECT) images and computed
tomography scans (CT) before and after hyperbaric oxygen treatment, were
compared. RESULTS: Before treatment, the proportion of abnormal
cerebral changes detected by SPECT was 81.3% but only 15.2% by CT.
After HBO treatment, 70.3% of SPECT scans showed no abnormalities and
these patients were clinically improved. Treatment improved regional
cerebral blood flow. CONCLUSION: SPECT was much more sensitive
than CT in the diagnosis of neuropsychiatric disorders following
hyperbaric oxygen treatment of neuropsychiatric disorders arising from
traumatic brain injury.
[Voldavsky and colleagues, (Vlodavsky, Palzur, & Soustiel, 2006)] found
in correlation with secondary cell death in the rat model of dynamic cortical
deformation (DCD). Twenty animals underwent DCD with subsequent
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HBOT (2.8 ATA, two sessions of 45 min each); 10 animals: DCD and
normobaric oxygenation (1 ATA), 10 animals: not treated after DCD. Cell
death was evaluated by TUNEL. Neutrophils were revealed by
myeloperoxidase staining. Immunohistochemical staining for MMP-2 and -
9 and tissue inhibitors of MMP-1 (TIMP-1) and -2 was also performed and
the results were quantitatively evaluated by image analysis. In the animals
treated by HBOT, a significant decrease in the number of TUNEL-positive
cells and neutrophilic inflammatory infiltration was seen in comparison
with non-treated animals and those treated by normobaric oxygen. The
expression of MMP-9 was also significantly lower in the treated group.
Staining for MMP-2 and TIMP-2 did not change significantly. Our results
demonstrate that HBOT decreased the extent of secondary cell death and
reactive neuroinflammation in the TBI model. The decline of MMP-9
expression after HBOT may also contribute to protection of brain tissue in
the perilesional area. Further research should be centered on the evaluation
of long-term functional and morphological results of HBOT.
(S. B. Rockswold, et al., 2001) studied oxygen (100% O2, 1.5 atm
absolute) was delivered to 37 patients in a hyperbaric chamber for 60
minutes every 24 hours (maximum of seven treatments/patient). Cerebral
blood flow, arteriovenous oxygen difference (AVDO2), cerebral metabolic
rate of oxygen (CMRO2), ventricular cerebrospinal fluid (CSF) lactate, and
ICP values were obtained 1 hour before and 1 hour and 6 hours after a
session in an HBO chamber. Patients were assigned to one of three
categories according to whether they had reduced, normal, or raised CBF
before HBO. In patients in whom CBF levels were reduced before HBO
sessions, both CBF and CMRO2 levels were raised 1 hour and 6 hours after
HBO (p < 0.05). In patients in whom CBF levels were normal before HBO
sessions, both CBF and CMRO2 levels were increased at 1 hour (p < 0.05),
but were decreased by 6 hours after HBO. Cerebral blood flow was reduced
1 hour and 6 hours after HBO (p < 0.05), but CMRO2 was unchanged in
patients who had exhibited a raised CBF before an HBO session. In all
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patients AVDO2 remained constant both before and after HBO. Levels of
CSF lactate were consistently decreased 1 hour and 6 hours after HBO,
regardless of the patient's CBF category before undergoing HBO (p <
0.05). Intracranial pressure values higher than 15 mm Hg before HBO were
decreased 1 hour and 6 hours after HBO (p < 0.05). The effects of each
HBO treatment did not last until the next session in the hyperbaric
chamber. CONCLUSIONS: The increased CMRO2 and decreased CSF
lactate levels after treatment indicate that HBO may improve aerobic
metabolism in severely brain-injured patients. This is the first study to
demonstrate a prolonged effect of HBO treatment on CBF and cerebral
metabolism. On the basis of their data the authors assert that shorter, more
frequent exposure to HBO may optimize treatment.
(Chang, et al., 2000) experimented on adult male Sprague-Dawley rats
weighing 250 -300 g were used in these experiments, Animals were
randomly assigned to HBO (n= 10) , HBP (n =10) , or NAP treatment
condition (n =5) . All tests were run blinded, and the animal codes were
revealed only at the end of the behavioral and histological, The MCA
embolic technique involved insertion of a neurofilament through the
carotid artery to reach the junction of the MCA, thus blocking the blood
flow from the common carotid artery. Animals exposed to HBO either
immediately after or 60 min after MCAo showed a significant amelioration
of asymmetrical behaviors as revealed by the elevated body swing test (65
and 55% contralateral biased swing, respectively) compared to animals
exposed to NAP ( 90%) animals exposed to HBO either immediately after
or 60 min after MCAo manifested a significant reduction (P < 0. 05) in
infarction volume compared to animals exposed to NAP. Animals exposed
to HBP immediately after MCAo also displayed significant reduction in
infarction volume (p < 0.05), but those exposed to HBP 60 min after
MCAo only showed trend (p=0.06) toward decreased infarction compared
to animals exposed to NAP. Animals exposed to HBO either immediately
after or 60 min after MCAo showed a significantly reduction (p< 0.05) in
incidence of infarction (20 and 16.7% incidence, respectably) compared to
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animal exposed to NAP (100%). He concluded that= The present
observation suggest that HBO attenuated ischemia-induced brain damage,
and behavioral dysfunctions, while HBO and HBP did not significantly
differed in some parameters of "protection" examined here. HBO produced
more consistent and effective than normal baric therapy. The main findings
in this study that HBO appears more effective than HBP. Although the
animals exposed to HBP have significant reduction in cerebral infarction
they did not show consistent recovery of motor deficits.
The evidence for use of HBOT in other types of brain injury is conclusive.
Some fair-quality studies were found. But to be able to confirm it we have
to do more randomized and qualitative studies.
Stroke
Although a large number of studies address HBOT for the treatment of
stroke, the evidence is insufficient to determine whether HBOT reduces
mortality in any subgroup of stroke patients because no controlled trial
assessed was designed to assess mortality.
Among controlled trials, the evidence about morbidity is conflicting. The
three best-quality trials found no difference in neurological measures in
patients treated with HBOT versus patients treated with pressurized room
air.
Two other controlled trials, one randomized and one nonrandomized, found
that HBOT improved neurological outcomes on some measures. However,
both were rated poor-quality.
Most observational studies reported favorable, and sometimes dramatic,
results, but failed to prove that these results can be attributed to HBOT. For
example, one retrospective study found better mortality rates in patients
who received HBOT than a comparison group of patients from a different
hospital who did not. The study did not provide information on mortality
rates from other causes in each hospital; this information would have made
it easier to judge whether the improved survival was due to HBOT
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or to differences in overall quality of care at the HBOT hospital.
The observational studies of HBOT provided insufficient evidence to
establish a clear relationship between
physiologic changes after HBOT sessions and measures of clinical
improvement. Few studies established that patients were stable at baseline.
There was a study and the result was decreased in oxygen
consumption occurred in brain slices when exposed to high HBO
pressure. (Mulkey, Henderson, Olson, Putnam, & Dean, 2001)
Adverse Events
Evidence about the type, frequency, and severity of adverse events in
actual practice is inadequate. Reporting of adverse effects was limited, and
no study was designed specifically to assess adverse effects.
The few data that are available from controlled trials and cohort studies of
TBI suggest that the risk of seizure may be higher in patients with brain
injuries treated with HBOT.
No study of HBOT for brain injury, cerebral palsy, or stroke has been
designed to identify the chronic neurologic complications.
Pulmonary complications were relatively common in the trials of brain-
injured patients. There are no reliable data on the incidence of aspiration in
children treated for cerebral palsy with hyperbaric oxygen.
Ear problems are a known potential adverse effect of HBOT. While ear
problems were reported in brain injury, cerebral palsy, and stroke studies
the incidence, severity and effect on outcome are not clear. However, the
rates
reported among cerebral palsy patients were higher (up to 47 percent
experiencing a problem) than reported with brain injury or stroke.
However, the data in brain injury are limited by the use of prophylactic
myringotomies.
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Supplemental Qualitative Analysis
Opinions about the frequency and severity of risks of HBOT vary widely.
Several participants emphasized the importance of continued treatments to
maximize results.
Patients and caregivers value any degree of benefit from HBOT highly. An
improvement that may appear small on a standard measure of motor,
language, or cognitive function can have a very large impact on caregiver
burden and quality of life.
Better outcome measures. In describing the course of their patients,
experienced clinicians who use HBOT to treat patients with brain injury,
cerebral palsy, and stroke refer to improvements that may be ignored in
standardized measures of motor and neuro-cognitive dysfunction. These
measures do not seem to capture the impact of the changes that clinicians
and parents perceive. Caregivers' perceptions should be given more weight
in evaluating the significance of objective improvements in a patient's
function. Unfortunately, studies have not consistently measured caregiver
burden, or have assessed it only by self-report. Studies in which the
caregivers' burden was directly observed would provide much stronger
evidence than is currently available about treatment outcome.
Adverse events. Uncertainty about the frequency and severity of serious
adverse events underlies much of the controversy about HBOT. The case
against HBOT is based on
The reasoning that, because HBOT may be harmful, it must be held to the
highest standard of proof. A corollary is that, if HBOT can be shown to be
as safe as its supporters believe it to be, the standard of proof of its efficacy
can be lowered.
Good-quality studies of adverse effects are designed to assess harms that
may not be known or even suspected. The most common strategy is to use
a standard template of several dozen potential adverse effects affecting
each organ system. Other characteristics of a good study of adverse events
are a clear description of patient selection factors, independent assessment
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of events by a neutral observer, and the use of measures for the severity
(rather than just the occurrence) of each event.
Unwillingness to be in a placebo group. The issue of placebo groups has
been the subject of a great deal of debate. Participants on both sides make
the assumption that an "evidence-based" approach implies devotion to
double blind, placebo-controlled trials without regard to practical or ethical
Considerations. This assumption is false. Double blind, placebo-controlled
trials are the "gold standard" for government regulators overseeing the
approval of new pharmaceuticals, but not for clinical decision making or
for insurance coverage decisions. Evidence-based clinical decisions rely
more heavily on comparisons of a treatment to other potentially effective
therapies than to placebos.
Several alternatives to the double blind, placebo-controlled trial can be
used to examine effectiveness. One approach is to compare immediate to
delayed treatment with HBOT, as was done in the Cornell trial. Another is
to design a trial in which patients are randomly assigned to several
alternative HBOT.
Regimens. Because of uncertainty about the dosage and duration of
treatment, such a trial would be preferable to a trial that offered a choice
between one particular regimen and no treatment at all. It is also easier to
incorporate a sham therapy arm in such a trial: patients may be more
willing to enter a trial if they have a 10 percent or 20 percent chance of
being assigned to sham treatment instead of a 50 percent chance. Other
alternatives to a placebo include conventional physical, occupational, and
recreational therapy, or another alternative therapy, such as patterning.
The Canadian trial of HBOT for cerebral palsy has important implications
for the design of future research. In the trial there was a clinically
significant benefit in the control group. Debate about the trial centers
largely on how the response in the control group should be interpreted. The
trial investigators believe that the beneficial effect was the result of the
psychological effect of participating in the trial and extra.
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Attention paid the children in and out of the hyperbaric chamber.
Alternatively, the slightly pressurized air (that is, "mild" hyperbaric
oxygen) may have caused the improvement. A third possibility is that the
slightly increased oxygen concentration, not the pressure per se, was
responsible for the benefit.
A trial that could sort out which of these explanations was true would have
a major impact on clinical practice. Such a trial might compare (1) room air
under slightly elevated pressure, delivered in a hyperbaric chamber, to (2)
elevated oxygen concentration alone, delivered in a hyperbaric chamber,
And to (3) an equal amount of time in a hyperbaric chamber, with room air
at atmospheric pressure. From the perspective of a neutral observer, the
third group is not a "sham" but rather an attempt to isolate the effect of the
social and psychological intervention cited by the Canadian investigators.
In addition to needing improved design, future trials of HBOT need better
reporting. This would aid interpretation and the application of the research
results. Two types of information are essential: a clear description of the
research design, particularly of the control and comparison groups, and
A detailed description of the patient sample. It is frequently difficult to tell
from published studies how comparable the patient populations are, not
only demographically but also clinically, in order to interpret the diagnosis
and prognosis.
HBOT for brain injury is not likely to gain acceptance in routine clinical
use until a clinical method of assessing its effectiveness in the individual
patient is validated. Specifically, the diagnostic value of SPECT scans and
of other intermediate indicators of the effects of HBOT should be examined
in good quality studies. Like all other diagnostic tests, SPECT scans have a
measurable false positive and false negative rate in relation to clinical
outcomes. Controlled trials are not needed as the ideal study design to
measure the accuracy of a diagnostic test. Rather, a longitudinal cohort
study in which all patients undergo scans as well as standardized follow-up
tests would be a feasible and ideal approach.
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Synthesis of Results
Results of data extraction and assessment of study validity are presented
bellow as a narrative description.
6 Results
In this review, we sought to analyze the effect of HBOT in acute ischemic
stroke by answering the question: the overall benefits regarding hyperbaric
oxygen therapy after acute ischemic stroke.
What is the relation between HBOT and free radicals "Oxidative
stress"?
Hyperbaric oxygenation has a several disadvantages, overall main
disadvantage is the free radicals "oxidative stress" and that the main debate
on now a day science. The free radical are produced normally in the
mitochondria under normal circumstances. And the other main
disadvantage is the possibility of oxygen toxicity.
Under normal circumstances, the rate of generation of superoxide from
mitochondria is rather low and dose little damage, simply because it is
efficiently removed by the superoxide dismutase's. Circumstance's can
arise for a variety of reasons (e.g. ingested chemicals that act as radical
amplifiers, medically applied high concentrations of oxygen, or during
periods of reperfusion of tissue with oxygen following ischemia).(Raha &
Robinson, 2000)
Alcohol-induced increases in the activity of the enzyme cytochrome
P450 2E1 (CYP2E1), which as described in the section "Systems
Producing ROS" metabolizes alcohol and other molecules and generates
ROS in the process. Alcohol-induced increases in the levels of free iron in
the cell (i.e: Iron that is not bound to various proteins), which can promote
ROS Generation, as described in the section "Role of Metals."(Wu &
Cederbaum, 2003)
Some mechanisms that related with CNS toxicity have been studied. The
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production of free radical and their toxic effect on brain, the disturbance of
neurotransmitter, endothelium derived relaxing factor (EDRF) and its
syntheses, constriction and/or dilation of blood vessel in brain and
metabolic dysfunction which was done by [Demchenko et al 2000 (W. Liu,
et al., 2008)] HBO exposure can induce a proportional increase in the rate
of formation of reactive oxygen species (ROS) such as superoxide anion,
singlet oxygen, and hydroxyl radical [Dircks and Faiman 1982; (W. Liu, et
al., 2008)], direct or indirect evidence for free radical generation in HBO
exposures were provided through several methods. ROS may evoke
seizures by various mechanism including excitotoxicity, metabolic
dysfunction, and disturbance of intracellular homeostasis of calcium.
Recent studies have implicated nitric oxide (NO) as a mediator of CNS
toxicity. NO is formed from agrinine by the action of one of three different
nitric oxide syntheses (NOS) isozymes which are two calcium-dependent
form, neuronal (nNOS) and endothelial (eNOS), and one calcium
independent form (iNOS).
Two lines of evidence supported the role of NO in epileptogenesis:
1. NO concentration in brain increases during exposure to HBO.
2. NOS, inhibitors, which block NO production, can protect rats and
mice against hyperoxic seizures (N. Bitterman & Bitterman, 1998;
M. Chavko, Braisted, Outsa, & Harabin, 1998).
(W. Liu, et al., 2008) repetitive HBO exposure (preconditioning)
could affect the sensitivity of mice to convulsions during
subsequent exposure to HBO.
[Claudia and colleagues,(Claudia Dennog, Andreas Hartmann,
Gunter Frey, & Gunter Speit, 1996)] the study we demonstrated for
the first time the induction of oxidative DNA damage by HBO. A
clear reproducible genotoxic effect was seen with the comet assay
immediately after HBO exposure (3x20 min at 2.5 ATA) as used
therapeutically.
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Dose the Dosage and exposure time in the chamber enhance the
production of free radicals?
Our result demonstrated that HBOT protect motor cortex and spinal
cord mitochondria from complex IV dysfunction in the Wobbler
mouse. A number of studies suggest that pronounced levels of free
radicals are only observed at either high pressure or long HBOT
exposure. Oxidative stress and resultant tissue damage are the
hallmark of cell death, there is increasing production and/or
ineffective scavenging of such reactive oxygen species may play a
crucial role in determining tissue injury. The level of intermediate
reduction products of oxygen metabolism (Yasar, et al., 2003).
There were some studies confirming that the dosage and the period
of exposure might increase the risk of oxidative stress, but further
qualitative studies have to confirm our findings.
Dose antioxidant and other medicaments maintain the production of
free radicals?
As we were searching through the data regarding a HBOT and antioxidants
or medications, we were not able to find qualitative studies and we mainly
found one study, which was a poor one, and the question wasn't answered.
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7 Conclusion
As we went through literatures including books and studies including
different kind of controlled and uncontrolled studies. (See appendix]
We determined whether the benefits of HBOT outweigh the potential
harms, there was a possibility that the patient would have oxygen toxicity
or free radical productions.
The main conclusion that the studies were done either with a high dosage
of the HBOT, or a long duration, repetition of the therapy was included in
the same day which lead by the end of the therapy to oxygen toxicity or the
production of free radical were present.
No controlled trial of HBOT was designed to measure mortality in stroke
patients, and the best studies found somewhat improvement in neurological
outcomes.
Evidence about the type, frequency, and severity of adverse events in actual
practice is inadequate.
Reporting of adverse effects was limited, and no study was designed
specifically to assess adverse effects. Evidence from well-conducted
clinical studies is limited.
The balance of benefits and harms of HBOT for brain injury, cerebral
palsy, or stroke has not been adequately studied.
We concluded that the HBOT has a promising great future for the
benefit of patients, health care and families of the patients. Diabetic
patient and post-cosmetics surgeries should promising prognosis.
More studies have to be done, to confirm the proper depth and
duration of the therapy to confirm its best result and prognosis in
stroke, cerebral edema. (See discussion and future research)
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R E C Q M M E D A T I O N FOR THE F U T U R E R E S E A R C H
A proper study which well involve giving the patient appropriate
medications that influence the improvement of the neurons and brain
activity, there is a lack of studies which patient were given medicaments,
there is no trails were given with medicaments to any of the articles we
went through beside vitamin supplement's which were taking during the
therapy in studies, (see the article review and appendix).
Strategies can be developed to conduct good-quality studies to overcome
each of these barriers. Dose and duration of treatment. Oxygen, the
"active ingredient" in HBOT, is fundamentally a drug. As for any drug,
dose and duration of treatment must be determined carefully designed dose-
ranging studies before definitive studies demonstrating clinical efficacy can
be started.
Good-quality dose-ranging studies of HBOT for brain injury can be done,
based on the model used by pharmaceutical manufacturers and the FDA.
It is likely that the dosage of HBOT needs to be individualized based on the
patient's age, clinical condition, and other factors.
This is the case for many other drugs and does not pose an insurmountable
barrier to designing dose finding trials. In fact, the need to individualize
therapy makes it essential to base the design of long-term studies of clinical
outcomes on the results of dose-ranging studies.
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Appendix 1: Animal experiments
Authors &
year
Smith et al
(1961)
Whalen et al
(1966)
Corkill et al
(1986)
Kawamura
etal(1990)
Authors &
year
Yatsuzuka
Animal
Model
Dogs
Dogs
Gerbils
Rats
Animal
Model
Dogs
Technique of
ischemia/anoxia
CO inhalation
Induced cardiac
fibrillation
Carotid ligation
Middle cerebral
artery occlusion
for4h
Technique of
ischemia/anoxia
Complete
Treatment
protocols
HBO 2ATA,
100% O2
controls, no
treatment
HBO 3 ATA,
100%
oxygen
controls, no
treatment
HBO 1.5 to
2 ATA with
100% O2;
control air
HBO at 2
ATA 100%
O2, for 30
min.
treatment
given
between 2.5-
3.5 h
following
ischemic
insult
Treatment
protocols
HBO at 2
Measurement and
results
Neurological recovery
facilitated; cortical
vessel diameter, no
change if CO2 is 40 mm
Prolonged the period
from fibrillation to
cessation of EEG
activity; cerebral
protection
Calorimetric
videodensimetric
estimation of cerebral
ischemia through intact
cranium; best results
obtained in HBO groups
HBO reduce ischemic
neuronal injury and
brain edema
Measurement and
results
CBF, EEG and
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(1991)
Takahashi et
al(1992)
Sunami et al
(2000)
Badr et al
(2000)
Authors &
Cats
Rats
Freely
moving
rats
Animal
cerebral
ischemia for 1 8
min
Global ischemia
induced by
occlusion of
ascending aorta
and caval veins
for 15 min.
Ligation of the
right MCA and
right common
carotid artery
MCA occlusion.
After 2 h of
occlusion the
suture was
removed and
reperfusion was
allowed
Technique of
ATA for 170
min
HBO at 3
ATA 100%
O2 for 1 h at
3, 24 & 29 h
after
ischemia,
controls;
room air
HBO
(3 AT A) 2 h,
initiated 10
min after
onset of
ischemia
HBO
(3ATA, 1 h),
100% O2
Treatment
indicators of oxidative
stress, HBO reduced
brain damage without
increasing oxidative
stress.
Survival rats were 30%
in control group Vs.
70% in-group treated
with HBO. Neurological
recovery with slight
disability was in 1 of 1 0
control animals vs. 6 out
of 9 animals in the
HBO-treated group
Reduced infarct volume
by increasing oxygen
supply to the ischemic
periphery without
aggravating lipid
peroxidation
Neuroprotective effect
as HBO normalized
brain energy metabolites
and excitatory amino
acids disturbances that
occur during cerebral
ischemia.
Measurement and
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year
Hjelde et al
(2000)
Yin et al
(2002)
Model
Wistar
rats
Rata
ischemia/anoxia
Right middle
cerebral
occluded for 4 h
Transient middle
cerebral artery
occlusion with
focal ischemia
protocols
HBO(2ATA,
100% O2 for
230 min)
HBO
(3 ATA, 100%
O2 for 1 h)
given 6 h
after
perfusion
results
HBO did not reduce
tissue damage
HBO within 6 h reduced
infarction, there was
inhibition of COX-2-over-
expression in cerebral
cortex accompanying the
neuroprotective effect
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Appendix 2: Uncontrolled Trails
Authors &
Year
Ingever and
Lassen
(1965)
Saltzman et
al (1966)
Neubauer
and End
(1980)
Ohta et al
(1985)
Hao & Yu
(1987)
Diagnosis
Focal cerebral ischemia
Acute cerebrovascular
insufficiency
Stroke; acute and chronic
cases"
CVD including infarction
and hemorrhage
Cerebral thrombosis
(782)
Cerebral embolism (16)
TIA(31)
Cerebral atherosclerosis
No. of
patien
ts
4
Single
treatm
ent
25
122
134
987
HBO Protocol
2 2.5 ATA
1.5 to 2.5 h
2-3 ATA, 2
h/day; 15
treatment
1. 5-2 ATA, 1
h/day within 1
h of onset of
stroke
2ATA
Pressure and
duration?? 20-
30 session
Method of Evaluation
& Result
Improvement in 3
patients; clinical EEG
8 improved dramatically;
5 improved during but
regressed later; 12 did
not improve
Total hospitalization stay
of treated patients was
177 days (287 days in
untreated patients);65 %
of chronic patients (5
months to 9 years)
improved
Overall improvement in
72 % patients; CBF
decreased with decrease
in intracranial pressure;
EEG and SSEP improved
Improvement in 82.3 %
of cases
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Sugiyama et
al(1987)
Gusev et al
(1990)
Cerebral infarction 1 -3
months after onset
Acute stroke
142
220
2 ATA for 75
min; 20 daily
session
1.2-1.3 ATA
Very good results in 15%
moderate improvement in
33%, and 20% showed
no effect
Normalization of EEG,
acid-base balance and
decreased of raised free
radicals by activation of
lipid peroxidation
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Appendix 3: Controlled Trails
Authors & Year
(D. C. Anderson, et al.,
1991)
(Nighoghossian, et al.,
1995)
(Rusyniak, et al., 2003)
No. Of
patients
39
34
33
Study Design
Double-blind
prospective study,
patients treated
within 2 w of
onset
Randomized: half
of the patients
received HBO,
the other half
were treated in
hyperbaric air,
patient treated
with 24 h of onset
Randomized,
prospective,
double-blind,
sham-controlled
study
HBO
Protocol
HBO 1 h at
1.5 ATA
repeated
every 8 h for
total of 15
treatment
HBO 40 m
at 1.5 ATA,
daily for 10
treatment
HBO 1 h at
2.5 ATA
(100% 02)o
1.14 ATA in
the sham
group
Results
Same schedule of
hyperbaric air in sham
group. Study aborted as
no dramatic
improvement was noted
in the HBO treated
patient
Control group received
hyperbaric air. HBO
was safe in these
patients and there was
an outcome trend
favoring HBO therapy
No differences between
the groups at 24 h. At 3
months sham patient
had a better outcome as
defined by their stroke
score.
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Appendix 4: Random studies with HBOT treatment:
Auth
or&
year
(Thur
ston,
et al.,
1973)
Poor
study
(Den
nog,
Rader
mach
er,
Barne
tt, &
Speit,
1999)
Fair
study
No of
patient/ Ani
mals
103 patients
HBO Vs.
105 control
group whom
were treated
conventional
ly in the
same cardiac
unit
7 Healthy
volunteers
(20-39
years) non-
smokers
Study design
Randomized control
study following
recent acute
myocardial infarction
Experimental, to
investigate whether
intake of antioxidants
may protect against
HBO-induced DNA
damage, we
supplemented
subjects with 3
volunteers with
Vitamin E(800mg),
and 4 with N-
acetylcysteine
(400mg) blood was
taken before and
after HBO sessions
HBO protocol
Patient were
exposed for
about 32 hours
in the chamber
only 57 of the
103 were in the
chamber
between 24-40
h the depth of
treatment and
the unknown
2.5 ATA a
total of 3X20
min periods
interspersed 5
min of air
breathing
Result
1 7 Patient whom were
treated with HBO died
(16.5%) compared with 24
(22.9 %), the overall
mortality among the 80
patients who were exposed
to a minimum of 4 hours in
HBO was (11. 3%)
HBO has no effect on
"antioxidant power" of
plasma in contrast, synthesis
of the heat shock protein
HSP70 which has been
implicated to play an
important role in cellular
protection against oxidative
stress which was found after
a single treatment
132
Auth
or&
year
No of
patient/Ani
mals
Study design HBO protocol Result
(Speit
, et
al,
2000)
fair
study
14 healthy
volunteer
(non-smoker
24-30 year)
Experimental study,
to indicate the DNA
damage after HBOT,
venous blood was
taken before & after
the session of HBO
or a day after
100% 02 at
2.5ATA for 20
min
interspersed
with 5 min
normal air
breathing
Induction of DNA damage
was found only after the
first HBO exposure and not
after further treatments.
Further more, blood was
taken 24h after HBOT was
significantly protected
against the induction of
DNA damage by H2O2,
indicating that adaptation
occurred due to indication
of antioxidant defenses.
(Dave
, et
al.,
2003)
Fair
study
50 Wobbler
mouse
Experimental
were divided
into 3 groups
the animals
were treated
28-30 days, the
study is to find
the
mitochondrial
dysfunction
and delays
onset of motor
neuron diseases
First group (n=18) 2
AT A of 100% O2
for 1 h a day in a
monoplace chamber,
the last HBOT
session was
conducted 24 h
before the
mitochondrial
isolation
Control group
(n=24) and not
subjected to HBOT
(n=8)
No significant differences
were found in state 3
respiration rate of
mitochondria isolated from
the motor cortex of all 3
experimental
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(Yasa
r, et
al.,
2003)
Good
study
45 Sprague-
Dawley rat
Experimental
study, to
investigate the
mechanism of
HBO on
oxidative stress
in Acute
Necrotizing
Pancreatitis
Group I Sham
group (n=15),
Group II
pancreatitis
(n=15), Group
III Pancreatitis
group
undergoing
HBOT(n=15)
for 5 days 2
sessions per
day at 2.5 ATA
for 90 min.
No complications related surgical
method and HBO were detected.
4 rats on the second day and one
rat on the third day died
following pancreatitis induction
in-group II. In Group III only two
rats died on the third day of the
study. (SOD) superoxide
dismutase were lower in group II
and III
(MDA) malondiladehyde the
level was higher in group II,III
compare to I
(GSH Px) Gluthathione
peroxidase in-group II was lower
compared to the other groups.
(Gule
c, et
aL,
2004)
36 Sprague-
Dawley rats
Experimental
Acute Distal
Colitis
randomly
divided into 3
groups
(Sham group I)
colitis induced by
acetic acid without
any therapy, (Group
I), colitis induced
with HBOT
(Group III) HBO
was given for 5
days 2 sessions per
day at 2.5 ATA for
90 min. (SOD),
(MDA),(GSH Px)
were measured in
intestinal tissue
All rats developed diarrhea,
(SOD) decreased
significantly in-group II
compare to group I, but
increased in-group III.
(MDA) were decreased in
group III compare to group II
(GSH Px) there was
decreased in-group II and I
compare to group III, which
showed increase.
(W.
Liu,
96 mice Mice were
randomly
HBO group, 60
min twice daily
Latency to seizures was
significantly shortened in mice
134
et al.,
2008)
(Rubi
nstein
,et
al.,
2009)
15 Male
Sprague-
Dawley rats,
assigned into 3
groups:
HBO (n=32),
HBA (n=32),
NBA (n=32)
The study was
to investigate
the
mechanisms in
increased
sensitivity to
convulsions &
role of Nitric
oxide after
HBO
Experimental
study if HBOT
improves GFR
in rats with
ischaemia/reper
fusion renal
injury: a
possible role
for the
antioxidant.
Oxidant
balance in the
ischaemic
kidney
for 3
consecutive
days (2.5 ATA
100%O2)24h
after last
exposure mice
were expose to
HBO (100% 6
ATA)
Hyperbaric air
group, normal
baric air group
Rats with left
kidney
ischemia
were
randomly
divided into 2
experimental
groups, I
(group +
HBO, n=9)
90 min each
2 h, and 22 h
after renal
ischaemia.
100% O2 to
2.5 ATA
after six HBO pre-exposure; the
level of NO in hypothalamus in
HBO group was increased. The
number of NADPH-d positive
cells and the levels of protein and
mRNA of eNOS and nNOS in
hypothalamus and hippocampus
were increased.
Conclusion^ after repeated HBO
exposure, elevated NO may
enhance the sensitivity to
convulsions & this may lead to
seizures during the subsequent
oxygen exposure, prevention of
seizures is needed when HBO is
used as preconditioning methods.
In the -HBO group, GFR was
reduced by 94% compared with the
untouched normal kidney
(ischaemic: 0.06 ± 0.03 ml/min,
normal: 1.02 ± 0.13 ml). In
contrast, in the +HBO group, GFR
of the ischemic kidney (0.36± 0.07
ml/min) was reduced only by 68%
compared with the contra lateral
normal kidney (1.1 2±0. 1 2 ml/min)
in line with these findings, HBO
improved the vasodilateraly
response to Ach as expressed in
enhancement of both total and
regional renal blood flow, in
135
Group II (-
HBO,n=6)
was left at
room
atmosphere
for 48 h
addition HBO reduced the
formation of 4-HNE by 33% and
76% and increased SOD by 30%
and 70% in the cortex and outer
stripe region of medulla of the
ischaemic kidney respectively.
Conclusion= HBO attenuates the
decline in GFR following renal
ischaemia, and improves
endothelial-dependent
vasorelaxation, suggesting that
treatment with HBO may be
beneficial in the setting of
ischaemic ARF
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